granisetron and Nausea

granisetron has been researched along with Nausea in 382 studies

Research

Studies (382)

TimeframeStudies, this research(%)All Research%
pre-19904 (1.05)18.7374
1990's188 (49.21)18.2507
2000's83 (21.73)29.6817
2010's87 (22.77)24.3611
2020's20 (5.24)2.80

Authors

AuthorsStudies
Hiraki, Y; Hori, M; Kawanaka, H; Matsuo, N; Miyashita, H; Miyoshi, T; Odawara, M1
Eom, YA; Jin, JY; Kang, JH; Kim, HK; Ko, YH; Park, SY; Sun, S; Woo, IS1
Araki, T; Nagamine, A; Obayashi, K; Ohshima, S; Takahashi, E; Takahashi, Y; Uchiyama, C; Yamamoto, K; Yashima, H1
Bao, Y; Li, X; Xu, K; Xu, X; Zhang, Z; Zhao, N1
Abd-ElGawad, M; Abdelhay, HM; Abdelmonem, H; Abdelwadoud, GT; Ahmed, AE; Al-Dardery, NM; Alhosini, ANM; Kamel, MA; Mohamed, SW1
Amano, Y; Hamaguchi, M; Hamaguchi, S; Hotta, T; Isobe, T; Itakura, M; Kuraki, T; Miura, K; Nakao, M; Okimoto, T; Tsubata, Y1
Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Feucht, J; Handgretinger, R; Hartmann, U; Koch, MS; Lang, P; Lange, V; Malaval, C; Mezger, M; Michaelis, S; Ost, M; Queudeville, M; Schober, S; Weber, S1
Abe, M; Arai, T; Fujita, Y; Hayasaki, Y; Iihara, H; Kado, N; Mori, M; Morishige, KI; Murase, S; Nakamura, K; Sakurai, M; Shimaoka, R; Shimokawa, M; Suzuki, A; Takenaka, M; Yamamoto, S1
Burckart, G; Garimella, N; Griebel, D; Heinrichs, MT; Kim, I; Krudys, K; Kumar, S; Mehrotra, N; Momper, JD; Mulberg, AE; Mulugeta, Y; Nelson, R; Reaman, G; Sachs, H; Sinha, V; Yao, L; Zineh, I1
Cabanillas Stanchi, KM; Döring, M; Flaadt, T; Handgretinger, R; Lang, P; Michaelis, S; Rupprecht, JV; Schlegel, P; Vek, J; Weber, S1
Aogi, K; Baba, M; Chiba, Y; Fujiwara, K; Hirano, G; Imamura, CK; Imoto, S; Matsumoto, K; Matsuura, K; Miyazaki, C; Naito, Y; Osaki, A; Saeki, T; Sato, K; Takahashi, M; Takano, T; Tamura, K; Tokunaga, S; Yanagihara, K1
Armbruster, SD; Coleman, RL; Eifel, PJ; Fellman, BM; Frumovitz, M; Jhingran, A; Klopp, AH; Ramondetta, LM1
Ebrahimi, M; Mehrzad, V; Moghaddas, A1
Chua, AV; Hernandez, ARB; Real, IO1
Carroll, E; Gamble, M; Glode, AE; Wright, GC1
Console, G; Ferreri, A; Gentile, M; Gori, M; Loteta, B; Martino, M; Morabito, A; Moscato, T; Naso, V; Paviglianiti, A; Pitino, AL; Porto, G; Provenzano, PF; Rossi, M; Tripepi, G1
Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y1
Arai, T; Fujita, Y; Funaguchi, N; Gomyo, T; Hakamata, J; Hirose, C; Iihara, H; Ikemura, S; Imai, H; Kaito, D; Kawazoe, H; Kotake, M; Minato, K; Ohno, Y; Okura, H; Sakai, C; Shimokawa, M; Suzuki, A1
A El-Azab, G; A Mahrous, M; A Tawfik, H1
Aizawa, F; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kanda, M; Murai, Y; Niimura, T; Okada, N; Yagi, K; Yoshida, A; Yoshioka, T; Zamami, Y1
Chen, CY; Hsu, CY; Hsu, YC; Tam, KW1
Chen, YX; Chen, ZD; Cheng, Y; Dang, CX; Dong, J; Han, BH; Hu, B; Li, BL; Li, JL; Liu, B; Lu, JG; Qin, SK; Shi, JH; Shu, YQ; Sun, XC; Wang, D; Wang, HB; Wang, KM; Wang, QM; Wu, Q; Yang, LQ; Zhang, HL; Zhang, QY; Zhang, ZH1
Yang, Y; Zhang, L1
Bernhardt, MB1
Doggrell, SA1
Iida, H; Kojima, Y; Matsumoto, S; Miyazawa, K; Nagai, H; Nakamura, A1
Akashi, K; Kadoyama, K; Kamezaki, K; Kato, K; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Takenaka, K; Uchida, M1
Nyktari, V; Papaioannou, A; Spartinou, A1
Ayuhara, H; Hama, T; Hayashi, T; Hirai, K; Inoue, K; Itoh, K; Kawasaki, Y; Kogure, Y; Nakao, M; Nishio, M; Shibata, K; Suzuki, K; Takeda, K; Tsuji, D; Yokoi, M1
Bai, D; Du, Y; Gao, Y; He, S; Jiang, Z; Lu, D; Wang, F; Wang, N; Wang, Z; Zhu, S1
Boccia, R; Calcanes, G; Caruana, D; McBride, A; Mosier, M; Vacirca, J1
Akashi, K; Hosohata, K; Ikesue, H; Kato, K; Makihara, Y; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Suetsugu, K; Uchida, M1
Akashi, K; Ariyama, H; Baba, E; Esaki, T; Hirano, G; Inadomi, K; Ito, M; Kumagai, H; Kusaba, H; Makiyama, A; Makiyama, C; Mitsugi, K; Nio, K; Shibata, Y; Shirakawa, T; Takayoshi, K; Tamura, S; Yamanaka, T1
Goldman, RD; Hasegawa, D; Kishimoto, K; Kosaka, Y; Ono, A1
Goto, K; Hama, T; Hashimoto, H; Itoh, K; Kawasaki, Y; Matsui, R; Seki, N; Suzuki, K; Tsuji, D; Yamamoto, N; Yamanaka, T1
Erickson, R; Mosier, MC; Nebughr, N; Nibley, W1
Gennari, A; Rondonotti, D1
Abe, M; Fujita, Y; Hayasaki, Y; Iihara, H; Matsuoka, R; Morishige, K; Nagasawa, Y; Sakurai, M; Shimokawa, M; Suzuki, A1
Araz, M; Artac, M; Beypinar, I; Inci, F; Karaagac, M; Koral, L; Korkmaz, L; Uysal, M1
Piccioni, AL1
Binder, G; Botteman, M; Corman, S; Nickel, K; Turini, M1
Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Yamada, Y; Yokoyama, H; Yoshimoto, K1
Abdul Kassim, MS; Keat, CH; Phua, G; Poh, WK; Sriraman, M1
Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Muta, T; Oishi, R; Sakurai, A; Shiratsuchi, M; Suetsugu, K; Takenaka, K; Teshima, T; Uchida, M1
Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Muta, T; Nagata, K; Oishi, R; Sakurai, A; Shiratsuchi, M; Suetsugu, K; Takenaka, K; Teshima, T; Uchida, M1
Goto, H; Myojo, T; Osawa, H1
Iwata, N; Kishi, T; Matsuda, Y; Mukai, T1
Ballinari, G; Barbour, SY; Cox, D; Morrow, GR; Schwartzberg, L; Thorn, MD1
Akasaka, J; Furukawa, N; Kawaguchi, R; Kobayashi, H; Nagai, A; Sasaki, Y; Shigemitsu, A1
Hashimoto, H; Murakami, M; Senba, S; Siraishi, T; Yamaguchi, I; Yamaguchi, K1
Billio, A; Clarke, MJ; Morello, E2
Kenjo, M; Kurisu, K; Nakamura, K; Nosaka, R; Saito, T; Sugiyama, K; Takayasu, T; Tominaga, A; Watanabe, Y; Yamasaki, F1
Ghani, NA; Keat, CH1
Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K1
Parkman, HP; Simmons, K1
Asano, K; Ito, Y; Kim, S; Ogura, Y; Tasaka, A; Yamamoto, K; Yamatodani, A1
Boccia, R; Cooper, W; Gabrail, N; Gralla, RJ; O'Boyle, E; Raftopoulos, H1
Brygger, L; Herrstedt, J1
Burhenne, J; Egerer, G; Freiberger, A; Goldschmidt, H; Gronkowski, M; Ho, AD; Hüsing, J; Mikus, G; Neben, K; Pelzl, le H; Schmitt, T; Thalheimer, M1
Ahn, JS; Hong, YS; Kim, JE; Kim, KP; Kim, TW; Lee, J; Lee, JL; Park, SJ; Park, YS; Shin, DB; Sym, SJ1
Ishimaru, K; Kaneko, K; Katsura, M; Takahashi, H; Takano, A; Yamaguchi, N1
Aoki, Y; Hayashi, K; Higuchi, T; Igarashi, K; Inatani, H; Kato, T; Kimura, H; Nishida, H; Shimozaki, S; Shirai, T; Takeuchi, A; Tanzawa, Y; Tsuchiya, H; Yamamoto, N1
Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L1
Doi, A; Hirayama, M; Kitayama, H; Kondo, T; Sugiyama, J; Tsuji, Y1
Ahmed, S; Badawi, AA; El-Nabarawi, MA; El-Setouhy, DA; Sallam, N1
Horita, H; Hotta, H; Kato, R; Kitamura, H; Kunishima, Y; Masumori, N; Takahashi, A; Takei, F1
Ishida, T; Isogai, Y; Kato, N; Kuroda, T; Yamamoto, K; Yamatodani, A1
Fujiwara, S; Kanemura, M; Ohmichi, M; Sasaki, H; Terai, Y; Tsunetoh, S1
Baek, JH; Choi, YJ; Chung, JS; Joo, YD; Kim, HJ; Kim, YS; Koh, SJ; Lee, EM; Lee, HG; Lee, WS; Oh, SY; Seol, YM; Yun, EY1
Boccia, R; Cooper, W; Gralla, RJ; O'Boyle, E; Raftopoulos, H1
Fujimura, T; Fushida, S; Kadoya, N; Kaji, M; Kinami, S; Kinoshita, J; Nezuka, H; Ohta, T; Ohyama, S; Oyama, K; Takai, Y; Takeda, T; Tsuji, K; Tsukada, T; Tsukioka, Y; Yabushita, K1
Arora, S; Chasen, M; Navari, R; Powers, D; Rapoport, B; Schnadig, I; Schwartzberg, L1
Cui, Y; Hayashinaka, E; Katayama, Y; Nakaoka, T; Okauchi, T; Onoe, K; Shingaki, T; Takashima, T; Wada, Y; Watanabe, Y1
Agajanian, R; Cooper, W; Dakhil, C; Gabrail, NY; Klepper, MJ; Mosier, MC; Payne, JY; Schnadig, ID; Schwartzberg, LS; Smith, RE; Taylor, C; Vacirca, JL; Wilks, ST1
Hou, F; Le, Q; Li, H; Li, W; Liu, S; Shi, Q; Zheng, L; Zong, S1
Hashizume, J; Higuchi, N; Kitahara, T; Kodama, Y; Matsunaga, N; Nakamura, T; Sakamoto, T; Sasaki, H; Sato, K; Yamaguchi, K1
Aogi, K; Inoue, K; Kitagawa, C; Kubota, K; Ogura, T; Saito, M; Sakai, H; Sekine, I; Yanagita, Y; Yoshizawa, H1
Coluzzi, F; Mattia, C1
Asada, K; Enomoto, N; Fujisawa, T; Hayakawa, H; Imokawa, S; Inui, N; Karayama, M; Kuroishi, S; Masuda, M; Nakamura, Y; Suda, T; Suzuki, S; Toyoshima, M; Watanabe, H; Yamada, T; Yokomura, K1
Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Sasaki, T; Tanabe, S; Wada, T; Yano, T1
Du, Q; Xu, XL; Yu, B; Zhai, Q; Zhu, B1
Arata, K; Azuma, K; Fujiwara, K; Goto, K; Hashimoto, H; Hayashi, T; Kogure, Y; Matsui, R; Nagase, S; Nakao, M; Nogami, N; Ohyanagi, F; Seki, N; Shimada, T; Shimada, Y; Suzuki, K; Takeda, K; Takiguchi, T; Yamamoto, N; Yamanaka, T1
Deeks, ED1
Bai, YX; Chen, YX; Chen, ZD; Cheng, Y; Han, BH; Li, YQ; Liu, JW; Liu, W; Ouyang, XN; Qin, SK; Shi, JH; Sun, XC; Wu, Q; Xu, JM; Yang, LQ; Yu, SY; Zhang, HL; Zhang, ZH1
de Kam, ML; Derijk, RH; Jacobs, GE; Kamerling, IM; van Gerven, JM; van Pelt, J; Zitman, FG1
Szántó, J; Tóth, J1
Morrow, T1
Aogi, K; Inoue, K; Kitagawa, C; Mitsuhashi, S; Ogura, T; Saito, M; Sakai, H; Sekine, I; Yanagita, Y; Yoshizawa, H1
Adams, LM; Johnson, B; Kirby, LC; Lebowitz, P; Stoltz, R; Yue, L; Zhang, K1
Drenth, HJ; Gill, D; Howell, J; Smeets, J1
Fujiwara, Y; Hashimoto, H; Hojo, T; Kaneko, M; Kato, Y; Katsumata, N; Kobayashi, Y; Satake, S; Takashima, A; Takeuchi, M; Yamamoto, H; Yonemura, M1
Du Bois, A1
Horiuchi, C; Ishitoya, J; Katori, H; Kimura, M; Matsuda, H; Mikami, Y; Nagao, J; Sakuma, Y; Taguchi, T; Toth, G; Tsukuda, M; Yoshida, T1
Curran, MP; Duggan, ST1
Schulmeister, L1
Chen, Q; Huang, C; Huang, J; Lin, T; Pan, L; Shen, H; Tian, W; Wang, J; Wang, Z; Zhang, L; Zhang, S; Zhou, J1
Becze, E1
Bi, F; Cao, D; Gou, HF; Hou, M; Jiang, M; Luo, de Y; Qiu, M; Shen, Y; Wang, J; Xu, F; Yang, Y; Yi, C; Zang, J; Zhou, XJ1
Eguchi, K; Hoshi, E; Katsumata, N; Kawahara, M; Takagi, M; Takahashi, T1
Boccia, RV; Clark, G; Gordan, LN; Grunberg, SM; Howell, JD1
Behlendorf, T; Jahn, F; Jahn, P; Jordan, K; Kegel, T; Ruessel, J; Schmoll, HJ; Stein, A1
Batu, ED; Büyükpamukçu, M; Civelek, E; Demir, HA; Saçkesen, C; Yalçın, B1
Endo, M; Murakami, H; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N1
Hassan, BA; Yusoff, ZB1
Daimon, T; Hashimoto, N; Ikematsu, Y; Kim, YI; Kimura, M; Maeda, M; Nakagaki, S; Taku, K; Tsubota, H; Tsuji, D1
Hafiz, MG; Islam, A; Jamal, CY; Rokeya, B; Siddique, R1
Abernethy, AP; Rangwala, F; Zafar, SY1
Abolhasani, E; Hashemian, F; Panahi, Y; Saadat, A; Sahebkar, A; Taghikhani, M1
Hori, K; Kawakami, J; Motohashi, S; Ohnishi, K; Ono, T1
Curran, MP; Duggan, ST; Keating, GM1
Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K1
Dakhil, SR; Heckler, CE; Kuebler, JP; Mohile, SG; Morrow, GR; Roscoe, JA; Wade, JL1
Eguchi, K; Katakami, N; Katsumata, N; Kawahara, M; Saito, H; Yoshimori, K; Yoshizawa, H1
Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S1
Fujimura, T; Fushida, S; Hirono, Y; Hirosawa, H; Kaji, M; Kimura, H; Kinami, S; Kinoshita, J; Nakano, T; Ohta, T; Oyama, K; Takai, Y; Takeda, T; Tsukada, T; Tsuneda, A; Yabushita, K; Yasui, T; Yoshimoto, K1
Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Oishi, R; Sakurai, A; Takenaka, K; Teshima, T; Uchida, M1
Markman, M1
Cooper, M; Smith, J; Sologuren, A; Valiente, R1
Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K1
Chen, Y; Cheng, G; Feng, F; He, Y; Li, Y; Zhang, P; Zhou, M1
Leelasiri, A; Mongkonsritragoon, W; Numbenjapon, T; Prayoonwiwat, W; Sriswasdi, C1
Fujii, Y; Tanaka, H1
Minami, M1
Steiner, MA; Theisen, J; Vermeulen, LC; Yorgason, RZ1
Fujii, Y; Kawasaki, T; Tanaka, H1
Prentice, HG1
Chen, G; Feng, F; He, Y; Li, L; Li, Y; Zhang, P; Zhou, M1
Tan, M1
Carmichael, J; Harris, AL1
Liu, YP; Shi, J; Teng, YE; Zhang, JD1
Coop, AJ; Dempsey, CL; Eberhardt, DR; Farley, PA; O'Briant, S; Shillington, A1
Seth, R; Tan, M; Xu, R1
Goldsmith, B1
Bradshaw, P; Callander, N; Clark, G; Freytes, CO; Holle, LM; Morris, AK; Valley, AW; Walsh, T1
Aapro, M1
Bhatnagar, S; Dua, N; Mishra, S; Singhal, AK1
Fibich, C; Grothey, A; Jordan, K; Kegel, T; Schöbert, C1
Barni, S; Cabiddu, M; Cazzaniga, M; Cremonesi, M; Di Cosimo, S; Ferretti, G; Ghilardi, M; Mandalà, M; Rocca, A1
Buyukavci, M; Ceviz, N; Olgun, H1
del Giglio, A; Moreno, J; Sahade, M1
Hamada, J; Kai, Y; Kochi, M; Kuratsu, J; Makino, K; Morioka, M; Nakamura, H; Yano, S1
Feyer, P; Seegenschmiedt, MH; Steingraeber, M1
Fukunaga, H; Ikeda, M; Ikenaga, M; Monden, M; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Yamamoto, H; Yasui, M1
Barr, J; Heller, J1
Aapro, M; Rabaeus, M1
Acar, S; Baysal, K; Dagdemir, A; Elli, M; Pinarli, FG1
Changkuingdee, N; Cheirsilpa, A; Chulaka, K; Sinthusake, T; Songsakkaesorn, A; Visawaprasit, S1
Abali, H; Aynacioglu, AS; Babaoglu, MO; Bayar, B; Bozkurt, A; Celik, I; Kerb, R1
Endo, K; Inoue, S; Itou, H; Nakamura, R1
Caran, EM; Luisi, FA; Petrilli, AS; Tanaka, C1
del Giglio, A; Lajolo, PP1
Awab, A; Chaudhary, L; Hamadani, M; Tfayli, A1
Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E1
Herrstedt, J1
Bakirci, N; Beker, B; Berrak, SG; Canpolat, C; Ozdemir, N; Turkkan, E; Yoruk, A1
Wilkes, G1
Awan, FT; Chaudhary, L; Hamadani, M; Khan, JK; Kojouri, K; Ozer, H; Tfayli, A1
Vrabel, M1
Buchanan, D; Muirhead, K1
Awata, H; Hashimoto, Y; Katayama, M; Kitagawa, J; Kodama, Y; Miyata, Y; Nakade, S; Ohno, T1
Iwase, O; Okuyama, K; Ozeki, T; Yamada, Y; Yoshimoto, K1
Enomoto, H; Furukawa, M; Furukawa, S; Kokatsu, T; Kubota, A; Tsukuda, M1
Imahori, T; Kasai, H; Kawamoto, K; Numa, Y; Tsuchida, T1
McTavish, D; Yarker, YE1
Perez, EA1
Becker, A; Debrix, I; Milleron, B; Puteaux, S1
Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T1
Nodoushani, M1
Fujii, Y; Tanaka, H; Toyooka, H18
Blower, P; Grélot, L; Milano, S; Romain, D1
Bremer, K; Cupissol, D; Dilly, SG; Goedhals, L; Noble, A1
Enomoto, H; Furukawa, M; Ikema, Y; Kawai, S; Kohno, H; Kubota, A; Makino, Y; Matsuda, H; Tsukuda, M; Yago, T1
Kagawa, T; Konishi, S; Moritake, K; Nagai, H; Nagao, S; Yamasaki, T1
Hayashida, S; Hirasawa, T; Mitsui, H; Nasu, T; Shinohara, Y; Uchiyama, K1
Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Takao, Y1
Fitts, D; Friedman, C; Gandara, D; Hall, S; Hesketh, P; Mailliard, J; Navari, R; Ritter, H1
Kattlove, H1
Arioka, H; Eguchi, K; Karato, A; Kunikane, H; Nakashima, H; Nisio, M; Ohe, Y; Ohmatsu, H; Shinkai, T; Tamura, T1
Böhm, S; Bresciani, G; Oriana, S1
Eguchi, F; Emoto, M; Hachisuga, T; Kawarabayashi, T; Mohtai, H; Shindo, M; Shirakawa, K1
Campana, F; Cosset, JM; Feuvret, L; Fourquet, A; Jammet, P1
Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, R1
Kawashima, T; Matsuhira, J; Morita, N; Okamoto, K; Sakamoto, T; Wada, T1
Cedar, E; Cunningham, J; Goedhals, L; Heron, JF; Jordaan, JP1
Blower, PR; Boyle, EA; Davey, PT; Marr, HE1
Osoba, D; Pater, J; Rusthoven, J; Slamet, L; Warr, D; Zee, B1
Soukop, M2
Ang, PT; Khoo, KS; Tan, EH1
Dilly, S2
Gandara, DR; Perez, EA1
Palmer, R1
Eisenberg, PD1
Hamada, T; Hayasaka, S; Ida, M; Kawano, S; Kuwahara, T; Matsumura, K; Nomura, H; Ueda, K; Ushijima, M; Yoshinaga, T1
Hanaoka, J; Hataya, I; Kodama, S; Maruhashi, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yanase, T; Yoshiya, N1
Cannata, G; Cipolla, C; Curto, G; Gebbia, N; Gebbia, V; Latteri, MA; Testa, A; Valenza, R1
Aapro, MS; Kirchner, V; Terrey, JP1
Riviere, A1
Enomoto, H; Furukawa, M; Furukawa, S; Kohno, H; Kokatsu, T; Kubota, A; Tsukuda, M1
Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T1
Fujimoto, T; Hirota, T; Honjo, T; Katano, N; Kuroda, R; Saeki, K; Sakakibara, Y; Shimizu, H2
Ohta, J; Taguchi, T; Tsukagoshi, S1
Daimaru, O; Fujimoto, T; Hirota, T; Kato, R; Koike, A; Kojima, T; Noda, A; Noguchi, M; Shimizu, H; Yabushita, H1
Adenis, L; Allen, A; Bessell, E; Bressolle, F; Carmichael, J; Cupissol, D; Romain, D; Wargenau, M1
Smith, IE2
de Wet, M; Falkson, G; Rapoport, BL1
Fukunaka, N; Ishioka, S; Itoh, E; Kitajima, Y; Kudo, R; Sagae, S; Sato, K1
Chevallier, B1
Furue, H; Niitani, H; Ogawa, N; Ohta, K; Suminaga, M; Taguchi, T2
Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K1
Aapro, MS2
Mori, K; Suga, Y; Takahashi, T; Tominaga, K1
Hiraoka, A; Kageyama, T; Kakishita, E; Masaoka, T; Matsuzawa, Y; Nagai, K; Okuda, K; Oshiba, S; Tatsumi, N; Uchino, H1
Kitada, M; Sawaragi, I1
Akaza, H; Hattori, K; Hinotsu, S; Ishikawa, S; Iwasaki, A; Kikuchi, K; Koiso, K; Kondo, F; Manabe, F; Nishijima, Y; Noguchi, R; Otani, M; Sato, K; Shimazui, T; Uchida, K1
Casey, PA; Terrey, JP1
Bianchi, A; Curreli, L; Ghiani, M; Macciò, A; Mantovani, G; Proto, E; Santona, MC1
Cannata, G; Gebbia, N; Gebbia, V; Testa, A; Tirrito, ML; Valenza, R1
Hickok, JT; Morrow, GR; Rosenthal, SN1
Collini, D; Fedele, P; Lucia, C; Manicone, M; Spina, M; Tirelli, U; Valentini, M1
Eisenberg, PD; Ettinger, DS; Fitts, D; Friedman, C; Wilson-Lynch, K; Yocom, K1
Diemunsch, P; Helbo-Hansen, HS; Kong, KL; Kroeks, MV; Lindeque, BG; Scheinin, H; Wilson, AJ1
Akazawa, S; Inai, T; Kagawa, S; Kanayama, H; Naruo, S; Ogawa, I; Sakurai, N; Sumitani, H; Takigawa, H; Yokoseki, H1
Angelelli, B; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E1
Alon, E; Biro, P1
Parasuraman, TV; Paska, W; Thwaites, R1
Bonneterre, J; Hecquet, B1
Fujishima, H; Hisano, C; Masumoto, N; Nakamura, M; Nakano, S; Niho, Y; Okuma, K1
Acito, L; Bascioni, R; De Signoribus, G; Giorgi, F; Giuliodori, L; Giustini, L; Marcellini, M; Menichetti, ET; Silva, RR1
Attia, M; Channa, AB; el Bakry, AK; el Gammal, K; el Gammal, M; Elhattab, YS; Jaroudi, R; Khoshim, MH; Naguib, M; Saddique, A1
King, RS; Krytzer, AC1
Contu, A; Depenni, R; Donati, D; Maestri, A; Meriggi, F; Olmeo, N; Piro, S; Sabbatini, R; Silingardi, V; Zaniboni, A1
Alberts, VA; Catalano, G; Poole, MA1
Cieslak, GD; Pennant, JH; Phillips, MB; Watcha, MF1
Teixeira, GM; Tremont-Lukats, IW1
Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, RH; Perez, EA1
Kubo, Y; Kurita, A; Nakata, M; Ohsumi, S; Saeki, H; Saiki, T; Takashima, S; Takiyama, W; Tanada, M; Yokoyama, N1
Aoyama, H; Babaya, K; Hayashi, Y; Hiramatsu, T; Hirao, YK; Kaneko, Y; Maruyama, Y; Matsuki, H; Momose, H; Natsume, O; Ohara, S; Okajima, E; Ozono, S; Sasaki, K; Shiomi, T; Tabata, S; Takashima, K; Watanabe, S; Yamada, K; Yoshikawa, M1
Tsukagoshi, S1
Aranda, E; Auclerc, G; Audhuy, B; Benhammouda, A; Bleiberg, H; Cals, L; Cappelaere, P; Cattan, A; Cervantes, A; Chevallier, B; Claverie, N; Conroy, T; Cupissol, D; De Grève, J; Diaz-Rubio, E; Fabbro, M; Faraldi, M; Khayat, D; Martin, M; Rivière, A; Seitz, JF1
Hatano, Y; Kato, N; Okuyama, N; Park, Y; Sasamoto, S; Yamazaki, S1
Chang, CS; Chen, LT; Chen, TP; Huang, SM; Lin, SF; Liu, TC; Wei, TC1
Akutagawa, N; Fukunaka, N; Hayashi, T; Kitajima, Y; Kudo, R; Mizumoto, H; Nakamura, T; Sagae, S; Sugimura, M; Terasawa, K; Wataba, K; Yamana, K1
Benline, TA; French, J1
Fukuoka, M; Furue, H; Furuse, K; Kawahara, M; Kusunoki, Y; Negoro, S; Ogawara, M; Takada, M1
Basurto, C; Ciccarese, G; Palladino, MA; Roila, F1
Fujii, M; Imanishi, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y1
Aoki, Y; Endo, M; Furue, H; Hanaoka, J; Honma, S; Kodama, S; Maruhashi, T; Oshima, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yoshiya, N1
Cunningham, RS1
Saphir, A1
Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Shiga, M; Takao, Y1
Bernstein, G; Colgan, K; Dempsey, CL; Farley, PA; Kulis-Robitaille, C; Shillington, AA1
Aapro, M; Alberto, P; Kirchner, V; Terrey, JP1
Chung, HC; Kim, BS; Kim, JH; Min, JS; Park, JO; Rha, SY; Roh, JK; Yoo, NC1
Diemunsch, PA; Houweling, PL; Rosen, M; Taylor, AM; Thorin, D1
Burish, T; Flynn, PJ; Hynes, HE; Morrow, GR; Pierce, HI; Roscoe, JA1
Bushnell, W; Chawla, S; Friedman, C; Hainsworth, J; Hesketh, P; Markman, M; Perez, EA; Reeves, J; Sandbach, J1
Baltzer, L; Berkery, R; Grossano, D; Kris, MG; Lucarelli, CD; Nolte, MJ; Pizzo, B1
Goto, S; Hirabayashi, N; Horibe, K; Kato, Y; Kodera, Y; Kojima, H; Matsuyama, T; Morishima, Y; Morishita, Y; Nagata, K; Naoe, T; Ogura, M; Saito, H; Sao, H; Tanimoto, M; Utsumi, M; Yamada, H; Yano, K; Yazaki, M1
Dhaliwal, H; Ernst, S; Findlay, B; Hoskins, P; Johnston, D; Laberge, F; Latreille, J; McMurtrie, E; Mee, D; Nishimura, L; Osoba, D; Pater, J; Rusthoven, J; Shepherd, F; Stewart, D; Walde, D; Warr, D; Williams, C; Yelle, L; Zee, B1
Fitts, D; Friedman, C; Gralla, RJ; Hall, SW; Hand, L; Ritter, HL; Wada, JK1
Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H4
Akashi, A; Ikeda, M; Kido, T; Minami, M; Nakahara, K; Nakamura, K; Ohta, M; Yasumitsu, T1
Bushnell, W; Einhorn, L; Ettinger, D; Friedman, C; Gralla, RJ; Hesketh, PJ; Navari, RM; Noy, J; Popovic, W; Strupp, J1
Fujii, H; Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakagawa, H; Nakao, M; Nakazawa, N; Ookawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S1
Agay, D; Fatôme, M; Martin, C; Roman, V1
Beresneva, IA; Gershanovich, ML1
Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K1
Clarke, J1
Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V1
Chow, LW; Poon, RT1
Finley, RS; Stull, DM; Trovato, JA1
Bolwell, B; Boparai, N; Jones, E; Kalaycio, M; Mendez, Z; Overmoyer, B; Pohlman, B1
Burghouts, J; de Wit, R; Fonteyn, M; Keizer, J; Nortier, J; Rodenburg, C; Slee, P; van den Berg, H; Verweij, J; Wils, J1
Carmichael, J; Cupissol, D; Keizer, HJ; Milliez, J; Scheidel, P; Schindler, AE1
Goedhals, L; Heron, JF; Kleisbauer, JP; Pagani, O; Sessa, C1
Ben Dayan, D; Ben Zion, T; Cohen, AM; Kaufman, O; Mittelman, M; Zeidman, A1
Bleuse, JP; Block, S; Bonneterre, J; Bonneterre, ME; Carlier, D; Darloy, F; Fournier, C; Huc, P1
Moriguchi, T; Tsudo, M1
Asakura, H; Doya, Y; Hara, H; Hata, K; Hatakeyama, S; Hirose, S; Ichida, T; Isokawa, O; Itoh, S; Nozawa, A; Ohta, H; Takagi, K; Tsuruya, T; Watanabe, T1
Ikeda, H; Koshiba, R1
Birch, R; Buckner, CD; Carson, K; Weaver, CH1
Hipple, TF; Morosco, RS; Nahata, MC1
McQuay, HJ; Moore, RA; Reynolds, DJ; Stoner, NS; Tramèr, MR1
Abbott, B; Bruton, J; Champlin, R; Ippoliti, C; Neumann, J; Whaley, R1
Ancona, G; Brunetti, P; Calò, A; Mattioli, V; Pisoni, G; Zollino, D1
Akaza, H; Hattori, K; Hinotsu, S; Ishikawa, S; Koiso, K; Kondo, F; Noguchi, R; Ohtani, M; Uchida, K1
Masaoka, T; Tatsumi, N1
Benfield, P; Plosker, GL1
Bercez, C; Bonneterre, J1
Fujii, Y; Kobayashi, N; Tanaka, H1
Granisétron, PK; Mabro, M1
Arthur, V; Devlin, J; Emery, P; Wagstaff, K1
Andersen, LJ; Dombernowsky, P; Havsteen, H; Herrstedt, J; Kjaer, M; Kjaerbøl, AG; Langer, SW; Lund, H; Sigsgaard, T1
Hirota, K; Kikuchi, H; Nakayama, T; Nasu, M; Ohno, E; Ohtuka, E; Ono, K; Saburi, Y; Uchida, I; Uno, N1
Kaneko, M; Matsumura, T; Mugishima, H; Ohira, M; Onuma, N; Sakurai, M; Sawada, T; Sugimoto, T; Takeda, T1
Perez, EA; Solberg, LA; Tiemeier, T1
O'Sullivan, GC; Shanahan, F1
Burns, L; DeFor, TE; Larson, H; Orchard, PJ; Ramsay, NK; Rogosheske, J; Rydholm, N; Weisdorf, D1
Fujiwara, K; Ishikawa, H; Kohno, I; Nagaji, M; Suzuki, S; Yamauchi, H1
Fujii, Y; Somekawa, Y; Tanaka, H1
Edelman, M; Gandara, DR; Hesketh, AM; Hesketh, PJ; Perez, EA; Roman, A1
Alkiş, N; Kartum, A; Oge, A; Oge, O1
Breatnach, F; Cohn, R; Gentet, JC; Hahlen, K; Mabro, M; Madon, E; Margueritte, G; Zanesco, L1
Andersen, O; Christensen, P; Dombernowsky, P; Herrstedt, J; Sigsgaard, T1
Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K1
Blackburn, LM; Burris, HA; Friedman, CJ; Gruben, D; Yocom, K1
Baron, PL; Cole, DJ; Maize, JC; McClay, EF; McClay, ME; Metcalf, JS; Monroe, L; O'Brien, PH1
Bushnell, W; Frankel, SR; Friedman, CJ; Raschko, J; Spitzer, TR1
Barrajon, E; de las Peñas, R1
Fukazawa, S; Fukushima, T; Hosoi, H; Ichikawa, Y; Ike, H; Kubo, A; Kunisaki, C; Moriwaki, Y; Obi, Y; Oki, S; Shimada, H; Suda, T; Takahashi, M; Takahashi, T; Togo, S; Yamaguchi, S; Yamazaki, Y1
Chen, PM; Chiou, TJ; Fan, FS; Liu, JH; Tzeng, WF; Wang, WS; Yen, CC1
Herrington, JD; Kwan, P; Lagow, E; Lagrone, L; Riggs, MW; Young, RR1
Klener, P; Procházka, B; Slabý, J; Trnený, M1
Araújo Pereira, ME; Carmo, JA; Juncal, C; Lacerda, JF; Lacerda, JM; Lourenço, MF; Martins, C; Rodrigues, A1
Caparroz, C; Castro, PC; del Giglio, A; Soares, HP1
Brown, MB; Hasler, WL; Ladabaum, U; Owyang, C; Pan, W1
Fujii, M; Imanishi, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y; Tomita, T1
Nakayama, S; Noda, T; Torii, Y1
Akman, SA; Aksoylar, S; Kansoy, S; Ozgenç, F1
Fisher, SG; Fletcher-Gonzalez, D; Fox-Geiman, MP; Kiley, K; Porter, N; Stiff, P1
Dranitsaris, G; Leung, P; Warr, D1
Friedman, C; Lanciano, R; Michalski, J; Preston, AJ; Sherman, DM; Yocom, K1
Feng, F; He, Y; Zhang, P1
Cui, C; Wang, J; Yang, L1
Allgar, V; Goss, I; Overend, M; Pedley, I; Riley, M; Watters, J; Whitehead, A1
Keefe, DL1
Kulp, B; Markman, M; Markman, MR; Peterson, G1
Aguerri, MF; Alby, N; Giacchetti, S; Imbeaux, PH1
Bremer, K1
Marty, M1
Blijham, GH1
Diehl, V1
Hacking, A1
Kamanabrou, D1
Blijham, GH; Bots, MW; Dijkstra, HJ; Fehmers, MC; Keizer, HJ; Nortier, JW; Siegenbeek van Heukelom, L; Slee, PH; van der Wall, E; Veenhof, CH1
Kaizer, L; Laberge, F; Latreille, J; O'Connell, G; Osoba, D; Pater, J; Stewart, D; Venner, P; Warr, D; Wilan, A1
Bosanquet, N; Jones, AL; Lee, GJ1
Aapro, M; Diehl, V; Kaye, SB; Khayat, D1
Davis, A; Erlichman, C; Fine, S; Laberge, F; Lofters, W; Osoba, D; Rusthoven, J; Warr, D; Willan, A; Wilson, K1
Amaral, D; Lemerle, J; Murdoch, RD; Southall, DP; Upward, J1
Goa, KL; Plosker, GL1
Falkson, CI; Falkson, G; Falkson, HC1
Addelman, M; Erlichman, C; Fine, S; Murray, C; Warr, D1
Nakao, I1
Caubel, M; Cupissol, DR; Serrou, B1
Brown, GW; Butcher, ME; Kidgell, AE1
Cantwell, BM; Carmichael, J; Edwards, CM; Harris, AL; Rapeport, WG; Thompson, S; Zussman, BD1
Falkson, G; van Zyl, AJ1
Cantwell, BM; Carmichael, J; Edwards, CM; Harris, AL; Rapeport, WG1
Brunner, KW; Joss, RA; Pirovino, M; Richner, J; Rohrbach, D; Terrey, JP; Upward, J1

Reviews

48 review(s) available for granisetron and Nausea

ArticleYear
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
    BMC neurology, 2023, Jun-08, Volume: 23, Issue:1

    Topics: Chlorpromazine; Granisetron; Headache; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Nausea; Network Meta-Analysis; Prochlorperazine; Randomized Controlled Trials as Topic; Sumatriptan; Valproic Acid

2023
Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:12

    Topics: Administration, Cutaneous; Administration, Oral; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Vomiting

2020
Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
    European journal of clinical pharmacology, 2021, Volume: 77, Issue:11

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Palonosetron; Quality of Life; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2021
Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:10

    Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Palonosetron; Quinuclidines; Vomiting

2017
Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.
    Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:12

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Nausea; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Vomiting

2017
Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.
    Neuromolecular medicine, 2014, Volume: 16, Issue:1

    Topics: Antipsychotic Agents; Constipation; Double-Blind Method; Drug Therapy, Combination; Granisetron; Haloperidol; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Risperidone; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Tropisetron; Vomiting

2014
WITHDRAWN: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
    The Cochrane database of systematic reviews, 2013, Dec-09, Issue:12

    Topics: Adult; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2013
5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.
    Expert opinion on drug safety, 2014, Volume: 13, Issue:10

    Topics: Aged; Antiemetics; Antineoplastic Agents; Cardiovascular Diseases; Granisetron; Humans; Isoquinolines; Long QT Syndrome; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2014
Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison.
    Oncotarget, 2016, Apr-26, Volume: 7, Issue:17

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neoplasms; Network Meta-Analysis; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Spiro Compounds; Treatment Outcome; Vomiting

2016
Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
    Future oncology (London, England), 2016, Volume: 12, Issue:16

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Transdermal Patch; Vomiting

2016
Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting.
    Drugs, 2016, Volume: 76, Issue:18

    Topics: Animals; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Granisetron; Humans; Injections; Nausea; Neoplasms; Vomiting

2016
[Prophylaxis of chemotherapy-induced vomiting and nausea].
    Magyar onkologia, 2008, Volume: 52, Issue:4

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Aprepitant; Granisetron; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Primary Prevention; Serotonin 5-HT3 Receptor Antagonists; Time Factors; Vomiting

2008
[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
    Medizinische Klinik (Munich, Germany : 1983), 1998, Volume: 93 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benchmarking; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Indoles; Metoclopramide; Nausea; Ondansetron; Premedication; Randomized Controlled Trials as Topic; Research; Serotonin 5-HT3 Receptor Antagonists; Tropisetron; Vomiting

1998
Transdermal granisetron.
    Drugs, 2009, Volume: 69, Issue:18

    Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Molecular Structure; Nausea; Receptors, Neurokinin-1; Receptors, Serotonin; Remission Induction; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting

2009
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
    The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1

    Topics: Adult; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2010
Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach.
    Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Gastrointestinal Diseases; Granisetron; Humans; Isoquinolines; Nausea; Neoplasms; Palliative Care; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting; Zingiber officinale

2012
Progress in preventing chemotherapy-induced nausea and vomiting.
    Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:8

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Granisetron; Humans; Indoles; Nausea; Neurotransmitter Agents; Ondansetron; Quinolizines; Vomiting

2002
Granisetron: is there a dose-response effect on nausea and vomiting?
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:2

    Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Granisetron; Humans; Nausea; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting

2003
Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:8

    Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Granisetron; Half-Life; Humans; Infusions, Intravenous; Nausea; Vomiting

2003
Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
    Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:9

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Humans; Indoles; Nausea; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting

2003
First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Acta oncologica (Stockholm, Sweden), 2004, Volume: 43 Suppl 15

    Topics: Age Factors; Aged; Antiemetics; Drug Resistance; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Radiotherapy; Receptors, Dopamine; Serotonin Antagonists; Vomiting

2004
Granisetron: an update on its clinical use in the management of nausea and vomiting.
    The oncologist, 2004, Volume: 9, Issue:6

    Topics: Antiemetics; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Interactions; Granisetron; Heart; Humans; Liver Failure; Nausea; Neoplasms; Radiotherapy; Renal Insufficiency; Vomiting

2004
Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:9

    Topics: Antiemetics; Antineoplastic Agents; Combined Modality Therapy; Granisetron; Humans; Nausea; Neoplasms; Radiotherapy; Serotonin Antagonists; Vomiting

2005
[Medical treatment of chemotherapy-induced nausea and vomiting].
    Ugeskrift for laeger, 2007, Feb-26, Volume: 169, Issue:9

    Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Benzodiazepines; Dexamethasone; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Ghrelin; Glucocorticoids; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Olanzapine; Palonosetron; Peptide Hormones; Practice Guidelines as Topic; Quinuclidines; Serotonin Antagonists; Vomiting

2007
Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.
    Clinical journal of oncology nursing, 2007, Volume: 11, Issue:6

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Evidence-Based Medicine; Granisetron; Humans; Meta-Analysis as Topic; Nausea; Ondansetron; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Research Design; Serotonin Antagonists; Treatment Outcome; Vomiting

2007
Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
    Drugs, 1994, Volume: 48, Issue:5

    Topics: Adult; Antineoplastic Agents; Child; Granisetron; Humans; Nausea; Randomized Controlled Trials as Topic; Vomiting

1994
Granisetron.
    Connecticut medicine, 1995, Volume: 59, Issue:4

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Nausea; Vomiting

1995
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting

1994
Granisetron (Kytril) clinical safety and tolerance.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Female; Granisetron; Humans; Infusions, Intravenous; Male; Nausea; Neoplasms; Vomiting

1994
The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5

    Topics: Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Granisetron; Humans; Nausea; Neoplasms; Serotonin Antagonists; Vomiting

1994
Efficacy and safety of granisetron (Kytril) in two special patient populations: children and adults with impaired hepatic function.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5

    Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Dexamethasone; Granisetron; Humans; Infant; Liver Failure; Liver Neoplasms; Nausea; Neoplasms; Vomiting

1994
Further profiles of granisetron (Kytril): effect on quality of life and pharmacoeconomics.
    Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Health Care Costs; Humans; Nausea; Neoplasms; Quality of Life; United States; Vomiting

1994
[An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15

    Topics: Antineoplastic Agents; Granisetron; Humans; Metoclopramide; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1993
Review of experience with ondansetron and granisetron.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4 Suppl 3

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1993
Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
    Cancer, 1995, Aug-01, Volume: 76, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Nausea; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting

1995
[Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1996, Volume: 31, Issue:4

    Topics: Antiemetics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Infusions, Intravenous; Nausea; Ondansetron; Postoperative Complications; Quinolizines; Serotonin Antagonists; Tropisetron; Vomiting

1996
[A new antiemetic ramosetron hydrochloride].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:3

    Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Granisetron; Guinea Pigs; Humans; Male; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1997
[Recent improvements in antiemetic therapy].
    Tumori, 1997, Volume: 83, Issue:2 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Indoles; Metoclopramide; Nausea; Ondansetron; Phenothiazines; Serotonin Antagonists; Tropisetron; Vomiting

1997
5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Oncology nursing forum, 1997, Volume: 24, Issue:7 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1997
Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:12

    Topics: Antiemetics; Granisetron; Humans; Nausea; Ondansetron; Radiotherapy; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting

1998
Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.
    PharmacoEconomics, 1996, Volume: 9, Issue:4

    Topics: Adult; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Quality of Life; Serotonin Antagonists; Vomiting

1996
Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT(3) regimen and literature review.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:6

    Topics: Administration, Oral; Adrenal Cortex Hormones; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Bone Marrow Transplantation; Drug Combinations; Granisetron; Humans; Infusions, Intravenous; Nausea; Ondansetron; Phenothiazines; Retrospective Studies; Safety; Serotonin Antagonists; Transplantation Conditioning; Treatment Outcome; Vomiting

1999
Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials.
    Cancer, 2000, Dec-01, Volume: 89, Issue:11

    Topics: Antiemetics; Antineoplastic Agents; Cross-Over Studies; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Randomized Controlled Trials as Topic; Serotonin Antagonists; Therapeutic Equivalency; Vomiting

2000
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?
    The oncologist, 2002, Volume: 7, Issue:1

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Electrocardiography; Granisetron; Heart Failure; Humans; Indoles; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting

2002
Are granisetron and ondansetron equivalent in the clinic?
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Imidazoles; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1992
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting

1991
[Gastrointestinal side effects of anticancer agents and their counter measures].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 2

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Indazoles; Nausea; Vomiting

1990
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
    Cancer treatment reviews, 1990, Volume: 17, Issue:2-3

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Granisetron; Headache; Humans; Imidazoles; Indazoles; Indoles; Nausea; Ondansetron; Radiation Injuries; Radiotherapy; Serotonin Antagonists; Tropisetron; Vomiting

1990

Trials

229 trial(s) available for granisetron and Nausea

ArticleYear
Palonosetron versus Granisetron in Combination with Aprepitant and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy: A Single-Institutional Retrospective Cohort Study.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:10

    Topics: Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Humans; Incidence; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Retrospective Studies; Treatment Outcome; Vomiting

2021
Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial.
    The Korean journal of internal medicine, 2023, Volume: 38, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Granisetron; Humans; Nausea; Ondansetron; Quality of Life; Vomiting

2023
Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis.
    Frontiers in public health, 2022, Volume: 10

    Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Dexamethasone; Granisetron; Humans; Morpholines; Nausea; Vomiting

2022
Translational and Randomized Study of 5-HT3 Receptor Antagonists for Evaluation of Chemotherapy-induced Nausea and Vomiting Related Biomarkers.
    The journal of medical investigation : JMI, 2019, Volume: 66, Issue:3.4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quality of Life; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2019
Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study.
    Gynecologic oncology, 2020, Volume: 156, Issue:3

    Topics: Adult; Aged; Antiemetics; Aprepitant; Carboplatin; Dexamethasone; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Olanzapine; Vomiting

2020
A double-blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy-induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophospham
    Cancer medicine, 2020, Volume: 9, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Palonosetron; Patient Reported Outcome Measures; Vomiting

2020
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021, Volume: 29, Issue:1

    Topics: Administration, Cutaneous; Adult; Antiemetics; Antineoplastic Agents; Cancer Survivors; Endometrial Neoplasms; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Quality of Life; Remission Induction; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vomiting

2021
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
    The oncologist, 2021, Volume: 26, Issue:6

    Topics: Carboplatin; Dexamethasone; Granisetron; Humans; Japan; Nausea; Olanzapine; Prospective Studies; Thoracic Neoplasms; Vomiting

2021
Evaluation of clinical outcomes and efficacy of palonosetron and granisetron in combination with dexamethasone in Egyptian patients receiving highly emetogenic chemotherapy.
    Cancer chemotherapy and pharmacology, 2021, Volume: 88, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Egypt; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Palonosetron; Quality of Life; Vomiting

2021
Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study.
    European journal of cancer care, 2017, Volume: 26, Issue:6

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Asian People; China; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Treatment Outcome; Vomiting; Young Adult

2017
[Electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting:a randomized controlled trial].
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2017, Apr-12, Volume: 37, Issue:4

    Topics: Acupuncture Therapy; Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Nausea; Neoplasms; Vomiting

2017
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy.
    Medicine, 2018, Volume: 97, Issue:25

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Therapy, Combination; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Prospective Studies; Serotonin Antagonists; Vomiting

2018
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019, Volume: 27, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nausea; Palonosetron; Risk Factors; Vomiting

2019
Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy and safety of combined triplet therapy and olanzapine for prevention of carboplatin-induced nausea and vomiting in gynaecological cancer patients.
    BMJ open, 2019, 01-17, Volume: 9, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Carboplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Olanzapine; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting

2019
Method for individualized evaluation of antiemetic effect induced by 5-HT3 receptor antagonist.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:5

    Topics: Aged; Antiemetics; Creatinine; Female; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Male; Middle Aged; Models, Biological; Nausea; Neoplasms; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists

2013
Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low- emetogenic chemotherapy?
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Logistic Models; Male; Metoclopramide; Middle Aged; Multivariate Analysis; Nausea; Neoplasms; Vomiting

2013
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting

2014
Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Surveys and Questionnaires; Vomiting

2014
Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
    Digestive diseases and sciences, 2014, Volume: 59, Issue:6

    Topics: Administration, Cutaneous; Adult; Antiemetics; Female; Gastroparesis; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting

2014
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, do
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Prospective Studies; Quinuclidines; Severity of Illness Index; Treatment Outcome; Vomiting

2015
Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-20, Volume: 32, Issue:30

    Topics: Aprepitant; Dexamethasone; Double-Blind Method; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Morpholines; Multiple Myeloma; Nausea; Prospective Studies; Quality of Life; Transplantation, Autologous; Vomiting

2014
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:6

    Topics: Administration, Cutaneous; Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Female; Fluorouracil; Granisetron; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasms; Organoplatinum Compounds; Prospective Studies; Remission Induction; Republic of Korea; Safety; Vomiting

2015
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-da
    Cancer medicine, 2015, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Bone Neoplasms; Cross-Over Studies; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Quinuclidines; Sarcoma; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting; Young Adult

2015
Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study.
    International journal of clinical oncology, 2015, Volume: 20, Issue:6

    Topics: Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Patient Preference; Prospective Studies; Quinuclidines; Single-Blind Method; Treatment Outcome; Vomiting

2015
Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
    Journal of gynecologic oncology, 2015, Volume: 26, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Cross-Over Studies; Diet; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Isoquinolines; Middle Aged; Morpholines; Nausea; Paclitaxel; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2015
Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:2

    Topics: Administration, Cutaneous; Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Patient Satisfaction; Quinuclidines; Remission Induction; Serotonin Antagonists; Vomiting

2016
Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.
    Future oncology (London, England), 2015, Volume: 11, Issue:18

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting

2015
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 57

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Ondansetron; Randomized Controlled Trials as Topic; Retreatment; Serotonin 5-HT3 Receptor Antagonists; Spiro Compounds; Treatment Outcome; Vomiting; Young Adult

2016
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
    Future oncology (London, England), 2016, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Subcutaneous; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Treatment Outcome; Vomiting; Young Adult

2016
Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:9

    Topics: Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Vomiting

2016
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.
    Medical oncology (Northwood, London, England), 2016, Volume: 33, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Paclitaxel; Pemetrexed; Vomiting

2016
Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).
    Anti-cancer drugs, 2016, Volume: 27, Issue:9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Cross-Over Studies; Dexamethasone; Esophageal Neoplasms; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Stomach Neoplasms; Vomiting

2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting

2016
Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
    Chinese clinical oncology, 2016, Volume: 5, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting; Young Adult

2016
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:1

    Topics: 5-Hydroxytryptophan; Adolescent; Adult; Antidepressive Agents, Second-Generation; Antiemetics; Area Under Curve; Carbidopa; Cross-Over Studies; Domperidone; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Granisetron; Humans; Hydrocortisone; Male; Nausea; Prolactin; Vomiting; Young Adult

2010
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    The Lancet. Oncology, 2009, Volume: 10, Issue:2

    Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting

2009
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:9

    Topics: Adolescent; Adult; Antiemetics; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Piperazines; Piperidines; Quinolizines; Vomiting; Young Adult

2009
Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2009, Volume: 15, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Aging; Antiemetics; Antineoplastic Agents; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Nausea; Sex Characteristics; Vomiting; Young Adult

2009
Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
    Japanese journal of clinical oncology, 2009, Volume: 39, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms; Prognosis; Single-Blind Method; Survival Rate; Treatment Outcome; Vomiting; Young Adult

2009
Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial.
    International journal of clinical oncology, 2009, Volume: 14, Issue:4

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Appetite; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Head and Neck Neoplasms; Humans; Male; Nausea; Neoplasm Staging; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Time Factors; Treatment Outcome; Vomiting

2009
Transdermal granisetron.
    Drugs, 2009, Volume: 69, Issue:18

    Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Molecular Structure; Nausea; Receptors, Neurokinin-1; Receptors, Serotonin; Remission Induction; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting

2009
Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Asian People; China; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Survival Rate; Treatment Outcome; Vomiting; Young Adult

2011
Antiemetic activity of megestrol acetate in patients receiving chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Megestrol; Metoclopramide; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Treatment Outcome; Vomiting

2011
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin.
    Cancer science, 2010, Volume: 101, Issue:11

    Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Hiccup; Humans; Japan; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Placebos; Treatment Outcome

2010
Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:10

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting

2011
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination.
    Bone marrow transplantation, 2011, Volume: 46, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granisetron; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Paclitaxel; Treatment Outcome; Vomiting; Young Adult

2011
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Immunoenzyme Techniques; Japan; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Morpholines; Nausea; Small Cell Lung Carcinoma; Substance P; Vomiting; Young Adult

2011
Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting; Young Adult

2012
Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Mymensingh medical journal : MMJ, 2011, Volume: 20, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Double-Blind Method; Female; Granisetron; Humans; Male; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting

2011
Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial.
    Integrative cancer therapies, 2012, Volume: 11, Issue:3

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Middle Aged; Nausea; Pilot Projects; Prevalence; Severity of Illness Index; Taxoids; Time Factors; Vomiting; Zingiber officinale

2012
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Sep-20, Volume: 30, Issue:27

    Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Intention to Treat Analysis; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Prochlorperazine; Quinuclidines; Serotonin Antagonists

2012
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4

    Topics: Adult; Aged; Aprepitant; Cisplatin; Dexamethasone; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Vomiting

2013
Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
    Oncology, 2003, Volume: 64, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Droperidol; Drug Therapy, Combination; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Premedication; Uterine Neoplasms; Vomiting

2003
[Nausea disintegrating buccal tablet in the prevention of gastrointestinal reaction induced by anticancer drugs].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2002, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Digestive System; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Tablets; Treatment Outcome; Vomiting

2002
Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:11

    Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cross-Over Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Metoclopramide; Middle Aged; Nausea; Patient Satisfaction; Prednisone; Probability; Treatment Outcome; Vincristine; Vomiting

2002
Granisetron versus granisetron/dexamethasone combination for the treatment of nausea, retching, and vomiting after major gynecologic surgery: a randomized, double-blind study.
    Clinical therapeutics, 2003, Volume: 25, Issue:2

    Topics: Adult; Aged; Anesthesia, General; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Middle Aged; Nausea; Time Factors; Treatment Outcome; Vomiting

2003
A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial.
    Clinical therapeutics, 2003, Volume: 25, Issue:4

    Topics: Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Mastectomy; Metoclopramide; Middle Aged; Nausea; Prospective Studies; Treatment Outcome; Vomiting

2003
Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2002, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Cross-Over Studies; Doxorubicin; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Serotonin Antagonists; Single-Blind Method; Vomiting, Anticipatory

2002
The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
    Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:2

    Topics: Adult; Antiemetics; Antineoplastic Agents; Area Under Curve; Cardiovascular Diseases; Electrocardiography; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting

2004
[Preventive effects of ramosetron and granisetron in prevention of gastrointestinal reaction associated with chemotherapeutic agents: a comparative study].
    Zhonghua yi xue za zhi, 2003, Dec-10, Volume: 83, Issue:23

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Appetite; Benzimidazoles; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting

2003
Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Apr-15, Volume: 61, Issue:8

    Topics: Adult; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cancer Care Facilities; Cohort Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Time Factors; Vomiting

2004
Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
    Current medical research and opinion, 2004, Volume: 20, Issue:6

    Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; United States; Vomiting

2004
Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Bone marrow transplantation, 2004, Volume: 34, Issue:11

    Topics: Antiemetics; Double-Blind Method; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Ondansetron; Prospective Studies; Transplantation Conditioning; Vomiting

2004
Granisetron and ondansetron for prevention of nausea and vomiting in patients undergoing modified radical mastectomy.
    Anaesthesia and intensive care, 2004, Volume: 32, Issue:6

    Topics: Adult; Aged; Analysis of Variance; Anesthesia, General; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Granisetron; Humans; Infusions, Intravenous; Mastectomy, Modified Radical; Middle Aged; Nausea; Ondansetron; Preoperative Care; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting

2004
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting.
    Onkologie, 2005, Volume: 28, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting

2005
Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:6

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Nausea; Neoplasms; Statistics, Nonparametric; Treatment Outcome; Vomiting

2005
The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
    American journal of clinical oncology, 2005, Volume: 28, Issue:2

    Topics: Adolescent; Antiemetics; Antimetabolites, Antineoplastic; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting

2005
Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.
    Neurologia medico-chirurgica, 2005, Volume: 45, Issue:6

    Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Brain Neoplasms; Female; Glioma; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting

2005
Clinical usefulness of oral granisetron hydrochloride for alleviation of delayed nausea and vomiting induced by CPT-11.
    European journal of cancer care, 2005, Volume: 14, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Granisetron; Humans; Irinotecan; Male; Middle Aged; Nausea; Pilot Projects; Vomiting

2005
Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer.
    Pediatric blood & cancer, 2006, Oct-15, Volume: 47, Issue:5

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Nausea; Neoplasms; Ondansetron; Predictive Value of Tests; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome

2006
Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Japanese journal of clinical oncology, 2005, Volume: 35, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cisplatin; Dizziness; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting, Anticipatory

2005
Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.
    Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Female; Gene Frequency; Genotype; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Polymorphism, Single Nucleotide; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Time Factors; Treatment Outcome; Tropisetron; Vomiting

2005
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
    Sao Paulo medical journal = Revista paulista de medicina, 2006, Mar-02, Volume: 124, Issue:2

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Child; Dimenhydrinate; Female; Granisetron; Humans; Male; Metoclopramide; Nausea; Osteosarcoma; Prospective Studies; Vomiting

2006
Skipping day 2 antiemetic medications may improve chemotherapy induced delayed nausea and vomiting control: results of two pilot phase II trials.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Brazil; Dexamethasone; Drug Hypersensitivity; Female; Granisetron; Humans; Hypersensitivity, Delayed; Logistic Models; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Pilot Projects; Quality of Life; Research Design; Serotonin Antagonists; Treatment Outcome; Vomiting

2007
A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Double Bind Interaction; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Infant; Male; Nausea; Treatment Outcome; Vomiting

2007
Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Cancer chemotherapy and pharmacology, 2008, Volume: 63, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Biological Availability; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Morpholines; Nausea; Vomiting

2008
Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:10

    Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting

1995
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting

1995
Granisetron-dexamethasone combination reduces postoperative nausea and vomiting.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1995, Volume: 42, Issue:5 Pt 1

    Topics: Adult; Aged; Anesthesia, General; Dexamethasone; Dizziness; Double-Blind Method; Drug Combinations; Female; Genitalia, Female; Granisetron; Headache; Humans; Middle Aged; Nausea; Placebos; Postoperative Complications; Sleep Stages; Vomiting

1995
A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: assessment of efficacy, safety and patient preference. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting

1994
Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. Italian Group for Antiemetic Research.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Italy; Logistic Models; Male; Middle Aged; Nausea; Prognosis; Vomiting

1995
[Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:10

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting

1995
[The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:5

    Topics: Aged; Angiotensin II; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Child; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Infusions, Intra-Arterial; Methylprednisolone; Nausea; Tegafur; Urinary Bladder Neoplasms; Vomiting

1995
The antiemetic efficacy of prophylactic granisetron in gynecologic surgery.
    Anesthesia and analgesia, 1995, Volume: 80, Issue:5

    Topics: Adult; Aged; Double-Blind Method; Female; Genitalia, Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Complications; Prospective Studies; Vomiting

1995
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Salvage Therapy; Vomiting

1995
A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
    Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:11

    Topics: Adult; Aged; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Multivariate Analysis; Nausea; Single-Blind Method; Vomiting

1994
Control of nausea and vomiting by granisetron in ovarian cancer patients treated with different cisplatin-based regimens.
    Tumori, 1994, Oct-31, Volume: 80, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Granisetron; Humans; Nausea; Ovarian Neoplasms; Treatment Outcome; Vomiting

1994
[The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:2

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clonazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting

1995
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10

    Topics: Adolescent; Adult; Aged; Cisplatin; Constipation; Diarrhea; Double-Blind Method; Female; Granisetron; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Serotonin; United States; Vomiting

1994
Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1994, Volume: 41, Issue:9

    Topics: Adult; Anesthesia Recovery Period; Anesthesia, Epidural; Double-Blind Method; Fallopian Tubes; Female; Granisetron; Humans; Hysterectomy; Middle Aged; Nausea; Ovariectomy; Placebos; Postoperative Complications; Time Factors; Vomiting

1994
Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer.
    The New England journal of medicine, 1995, Jan-05, Volume: 332, Issue:1

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Prospective Studies; Vomiting

1995
[Clinical effects of granisetron and methylpredonisolone against delayed emesis and anorexia induced by anticancer agents].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:16

    Topics: Anorexia; Antineoplastic Agents; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting

1994
Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Granisetron; Headache; Humans; Male; Metoclopramide; Middle Aged; Nausea; Prognosis; South Africa; Vomiting

1994
Reduction of postoperative nausea and vomiting with granisetron.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1994, Volume: 41, Issue:4

    Topics: Adult; Anesthesia, General; Female; Granisetron; Humans; Middle Aged; Nausea; Vomiting

1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting

1994
A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Awareness; Blood Pressure; Body Temperature; Cisplatin; Double-Blind Method; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Patient Satisfaction; Pulse; Time Factors; Vomiting

1994
Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Constipation; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Flushing; Granisetron; Headache; Humans; Injections, Intravenous; Metoclopramide; Middle Aged; Nausea; Tablets; Vomiting

1994
[Clinical effects and safety of granisetron administration against CDDP chemotherapy in lung cancer. Lung Cancer Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Vomiting

1994
[Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Vomiting

1994
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial.
    Cancer, 1994, Oct-01, Volume: 74, Issue:7

    Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting

1994
Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.
    British journal of cancer, 1994, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Aged; Cisplatin; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting

1994
[Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:13

    Topics: Adult; Aged; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Head and Neck Neoplasms; Humans; Hydroxyzine; Male; Middle Aged; Nausea; Vomiting

1993
[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:13

    Topics: Adult; Aged; Anorexia; Cisplatin; Domperidone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mouth Neoplasms; Nausea; Vomiting

1993
[Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Humans; Male; Nausea; Neoplasms; Vomiting

1993
[Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Nausea; Neoplasms; Vomiting

1993
[Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting

1994
Evaluation of the bioequivalence of tablet and capsule formulations of granisetron in patients undergoing cytotoxic chemotherapy for malignant disease.
    Journal of pharmaceutical sciences, 1993, Volume: 82, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Agents; Capsules; Chemistry, Pharmaceutical; Female; Granisetron; Humans; Male; Nausea; Neoplasms; Tablets; Therapeutic Equivalency; Vomiting

1993
A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy. The Granisetron Study Group.
    Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:6

    Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Infant, Newborn; Injections, Intravenous; Nausea; Vomiting

1993
The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group.
    British journal of cancer, 1993, Volume: 68, Issue:1

    Topics: Blood Pressure; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pulse

1993
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Vomiting

1993
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9

    Topics: Administration, Oral; Antiemetics; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Tablets; Vomiting

1993
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting

1993
[Granisetron oral phase III clinical trial--study on the inhibitory effect of granisetron for nausea/vomiting induced by chemotherapy for tumors in the hematopoietic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Granisetron; Hodgkin Disease; Humans; Indazoles; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Vomiting

1993
[Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1996
[Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Stud
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:1

    Topics: Aged; Antiemetics; Cisplatin; Cross-Over Studies; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Urogenital Neoplasms; Vomiting

1996
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Cancer, 1996, Mar-01, Volume: 77, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Head and Neck Neoplasms; Humans; Indoles; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting

1996
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Cancer, 1995, Nov-15, Volume: 76, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prospective Studies; Vomiting

1995
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
    Cancer, 1995, Aug-01, Volume: 76, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting

1995
A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
    Cancer, 1996, Jul-01, Volume: 78, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Remission Induction; Sex Factors; Vomiting

1996
Single-dose i.v. granisetron in the prevention of postoperative nausea and vomiting.
    British journal of anaesthesia, 1996, Volume: 76, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Postoperative Complications; Preanesthetic Medication; Risk Factors; Vomiting

1996
[Efficacy of granisetron rescue therapy for nausea and vomiting induced by cancer chemotherapies in urogenital malignant tumor].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Male; Methotrexate; Middle Aged; Nausea; Urogenital Neoplasms; Vinblastine; Vomiting

1996
An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1

    Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting

1996
Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidol.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1995, Volume: 42, Issue:10

    Topics: Adult; Aged; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Complications; Vomiting

1995
Granisetron (IV) compared with ondansetron (IV plus oral) in the prevention of nausea and vomiting induced by moderately-emetogenic chemotherapy. A cross-over study.
    Bulletin du cancer, 1995, Volume: 82, Issue:12

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Treatment Outcome; Vomiting

1995
[Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Drug Therapy, Combination; Female; Fluorouracil; Granisetron; Humans; Leucovorin; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting

1996
Antiemetic effects of granisetron on postoperative nausea and vomiting in patients with and without motion sickness.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1996, Volume: 43, Issue:2

    Topics: Adult; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Middle Aged; Motion Sickness; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting

1996
Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1996, Volume: 4, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting

1996
Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1996, Volume: 43, Issue:3

    Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Postoperative Complications; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting

1996
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy.
    Anti-cancer drugs, 1995, Volume: 6, Issue:5

    Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Cross-Over Studies; Female; Granisetron; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting

1995
The dose-response relation and cost-effectiveness of granisetron for the prophylaxis of pediatric postoperative emesis.
    Anesthesiology, 1996, Volume: 85, Issue:5

    Topics: Adolescent; Antiemetics; Child; Child, Preschool; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Male; Nausea; Parents; Postoperative Complications; Vomiting

1996
Comparison of Granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer. A randomized controlled trial.
    Cancer, 1996, Dec-01, Volume: 78, Issue:11

    Topics: Acute Disease; Antiemetics; Antineoplastic Agents; Cisplatin; Data Interpretation, Statistical; Granisetron; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Tropisetron

1996
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Appetite; Cisplatin; Female; Follow-Up Studies; Granisetron; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Remission Induction; Safety; Time Factors; Vomiting

1997
[Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:1

    Topics: Antiemetics; Chemotherapy, Adjuvant; Cisplatin; Female; Gastrectomy; Granisetron; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Stomach Neoplasms; Vomiting

1997
[A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Na
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:3

    Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Male; Granisetron; Humans; Kidney Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Prostatic Neoplasms; Registries; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting

1997
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Quinolizines; Serotonin Antagonists; Vomiting

1996
Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1997, Volume: 44, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Antiemetics; Chemoprevention; Cholecystectomy, Laparoscopic; Dopamine Antagonists; Droperidol; Elective Surgical Procedures; Female; Follow-Up Studies; Granisetron; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Nausea; Placebos; Postoperative Complications; Premedication; Safety; Serotonin Antagonists; Vomiting

1997
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:6

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1997
Granisetron reduces postoperative nausea and vomiting throughout menstrual cycle.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1997, Volume: 44, Issue:5 Pt 1

    Topics: Adult; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Menstrual Cycle; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting

1997
Anti-emetic drug effects on cognitive and psychomotor performance: granisetron vs. ondansetron.
    Aviation, space, and environmental medicine, 1997, Volume: 68, Issue:6

    Topics: Adolescent; Adult; Affect; Antiemetics; Cognition; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Granisetron; Humans; Male; Nausea; Ondansetron; Psychomotor Performance; Radiotherapy; Vomiting

1997
[Clinical evaluation of 2 mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:8

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Tablets; Vomiting

1997
[Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Injections; Male; Middle Aged; Nausea; Vomiting

1997
[Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Tablets; Uterine Neoplasms; Vomiting

1997
Granisetron reduces incidence of nausea and vomiting after breast surgery.
    Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:6

    Topics: Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting

1997
Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1997, Volume: 44, Issue:8

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Motion Sickness; Nausea; Postoperative Complications; Vomiting

1997
Optimal dose of granisetron for prophylaxis against postoperative emesis after gynecological surgery.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:3

    Topics: Adult; Aged; Antiemetics; Female; Genitalia, Female; Granisetron; Humans; Hysterectomy; Middle Aged; Nausea; Ovariectomy; Postoperative Complications; Premedication; Vomiting

1997
Patients' self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Nov-01, Volume: 54, Issue:21

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Vomiting

1997
Effective dose of granisetron in the reduction of nausea and vomiting after breast surgery.
    Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:9

    Topics: Adult; Aged; Anesthesia; Antiemetics; Breast; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Postoperative Complications; Vomiting

1997
Granisetron reduces the incidence of nausea and vomiting after middle ear surgery.
    British journal of anaesthesia, 1997, Volume: 79, Issue:4

    Topics: Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Ear, Middle; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Postoperative Complications; Preanesthetic Medication; Vomiting

1997
A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment in controlling nausea and vomiting associated with chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Granisetron; Humans; Male; Middle Aged; Nausea; Patient Satisfaction; Serotonin Antagonists; Treatment Outcome; Vomiting

1997
A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy.
    American journal of clinical oncology, 1997, Volume: 20, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting

1997
A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia.
    Journal of clinical anesthesia, 1997, Volume: 9, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Postoperative Complications; Vomiting

1997
Progress in reducing anticipatory nausea and vomiting: a study of community practice.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Treatment Outcome; Vomiting

1998
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Vomiting

1998
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Antiemetics; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Melphalan; Middle Aged; Nausea; Serotonin Antagonists; Transplantation Conditioning; Vomiting; Whole-Body Irradiation

1998
Prevention of postoperative nausea and vomiting with a combination of granisetron and droperidol.
    Anesthesia and analgesia, 1998, Volume: 86, Issue:3

    Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Drug Combinations; Female; Granisetron; Humans; Middle Aged; Nausea; Postoperative Period; Prospective Studies; Serotonin Antagonists; Vomiting

1998
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Linear Models; Logistic Models; Male; Middle Aged; Nausea; Serotonin Antagonists; Statistics, Nonparametric; Vomiting

1998
Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo.
    Acta anaesthesiologica Scandinavica, 1998, Volume: 42, Issue:2

    Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting

1998
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
    Cancer investigation, 1998, Volume: 16, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug Evaluation; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting

1998
Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1998, Volume: 45, Issue:2

    Topics: Adult; Double-Blind Method; Droperidol; Female; Gastrointestinal Agents; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Vomiting

1998
[Effect of granisetron in preventing emesis due to anti-cancer drug (CDDP) administration pulmo-mediastinal malignancies--comparison of simultaneous infusion with the conventional method of administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:4

    Topics: Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Nausea; Vomiting

1998
Granisetron prevents nausea and vomiting during spinal anaesthesia for caesarean section.
    Acta anaesthesiologica Scandinavica, 1998, Volume: 42, Issue:3

    Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Method; Female; Granisetron; Humans; Nausea; Pregnancy; Vomiting

1998
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:4

    Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron

1998
[Clinical study on the inhibitory effect of a 5-HT3 antagonist, granisetron, for nausea and vomiting induced by chemotherapy (CHOP, VEPA, high-dose ETP) for non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Serotonin Antagonists; Vincristine; Vomiting

1998
Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial.
    European journal of anaesthesiology, 1998, Volume: 15, Issue:2

    Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Vomiting

1998
Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron.
    British journal of anaesthesia, 1998, Volume: 80, Issue:2

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Menstruation; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting

1998
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:6

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1998
Comparison of antiemetic efficacy of granisetron and ondansetron in Oriental patients: a randomized crossover study.
    British journal of cancer, 1998, Volume: 77, Issue:10

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Granisetron; Hong Kong; Humans; Middle Aged; Nausea; Ondansetron; Vomiting

1998
Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
    Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Treatment Outcome; Vomiting

1998
Effective dose of granisetron for the prevention of post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
    European journal of anaesthesiology, 1998, Volume: 15, Issue:3

    Topics: Adult; Anesthetics, Inhalation; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Elective Surgical Procedures; Female; Granisetron; Humans; Incidence; Injections, Intravenous; Isoflurane; Middle Aged; Nausea; Nitrous Oxide; Oxygen; Placebos; Postoperative Complications; Premedication; Probability; Prospective Studies; Serotonin Antagonists; Vomiting

1998
Use of granisetron in patients refractory to previous treatment with antiemetics.
    Anti-cancer drugs, 1998, Volume: 9, Issue:5

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Child; Cisplatin; Constipation; Drug Resistance; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Serotonin Antagonists; Treatment Outcome; Vomiting

1998
Prophylactic antiemetic therapy with granisetron-droperidol combination in patients undergoing laparoscopic cholecystectomy.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1998, Volume: 45, Issue:6

    Topics: Adult; Aged; Anesthetics, Inhalation; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Droperidol; Drug Combinations; Female; Follow-Up Studies; Granisetron; Humans; Incidence; Injections, Intravenous; Isoflurane; Middle Aged; Nausea; Nitrous Oxide; Oxygen; Postoperative Complications; Premedication; Remission Induction; Treatment Outcome; Vomiting

1998
Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double-blind, placebo-controlled, comparative study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Odds Ratio; Proportional Hazards Models; Serotonin Antagonists; Time Factors; Treatment Outcome; Vomiting

1998
Preoperative oral granisetron prevents postoperative nausea and vomiting.
    Acta anaesthesiologica Scandinavica, 1998, Volume: 42, Issue:6

    Topics: Administration, Oral; Adult; Anesthesia; Antiemetics; Double-Blind Method; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Middle Aged; Nausea; Postoperative Complications; Premedication; Prospective Studies; Vomiting

1998
Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
    Haematologia, 1998, Volume: 29, Issue:1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Vomiting

1998
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord].
    Bulletin du cancer, 1998, Volume: 85, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Male; Methotrexate; Nausea; Ondansetron; Prednisone; Vindesine; Vomiting

1998
[Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus in
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting

1998
Granisetron in the prevention of nausea and vomiting after middle-ear surgery: a dose-ranging study.
    British journal of anaesthesia, 1998, Volume: 80, Issue:6

    Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Mastoid; Middle Aged; Nausea; Postoperative Complications; Serotonin Antagonists; Tympanoplasty; Vomiting

1998
[Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Vomiting

1998
[Comparison of antiemetic efficacy of granisetron as premedication versus combination therapy of granisetron].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12

    Topics: Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Premedication; Vomiting

1998
Prophylactic antiemetic therapy with granisetron-dexamethasone combination in women undergoing breast surgery.
    Acta anaesthesiologica Scandinavica, 1998, Volume: 42, Issue:9

    Topics: Adult; Aged; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Mastectomy; Middle Aged; Nausea; Postoperative Complications; Vomiting

1998
A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    Bone marrow transplantation, 1998, Volume: 22, Issue:7

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Middle Aged; Nausea; Thiotepa

1998
Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Bone marrow transplantation, 1999, Volume: 23, Issue:3

    Topics: Activities of Daily Living; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Diarrhea; Drug Therapy, Combination; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Premedication; Prospective Studies; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Safety; Transplantation Conditioning; Treatment Outcome; Vomiting; Whole-Body Irradiation

1999
Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. A multicentre, double-blind, randomised, parallel group, placebo-controlled study.
    Minerva anestesiologica, 1998, Volume: 64, Issue:12

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Double-Blind Method; Female; Fluorescein Angiography; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting

1998
Antiemetic efficacy of granisetron: a randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy.
    Japanese journal of clinical oncology, 1999, Volume: 29, Issue:2

    Topics: Adolescent; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Nausea; Prospective Studies; Urinary Bladder Neoplasms; Vomiting, Anticipatory

1999
A comparative study of administration methods of granisetron injection used to treat nausea/vomiting induced by cancer chemotherapy without cisplatin in tumors of hematopoietic organs. Keihanshin Study Group of Hematological Malignancies.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:5

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting

1999
Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy.
    The Laryngoscope, 1999, Volume: 109, Issue:4

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Prospective Studies; Thyroidectomy; Treatment Outcome; Vomiting

1999
[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
    Bulletin du cancer, 1999, Volume: 86, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Breast Neoplasms; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Vomiting

1999
Granisetron (Kytril) suppresses methotrexate-induced nausea and vomiting among patients with inflammatory arthritis and is superior to prochlorperazine (Stemetil).
    Rheumatology (Oxford, England), 1999, Volume: 38, Issue:3

    Topics: Antiemetics; Arthritis; Granisetron; Humans; Methotrexate; Nausea; Prochlorperazine; Single-Blind Method; Vomiting

1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
    British journal of cancer, 1999, Volume: 80, Issue:3-4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Methotrexate; Middle Aged; Nausea; Prednisolone; Serotonin Antagonists; Vomiting

1999
[Efficacy of combination with granisetron and methylprednisolone for nausea, vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia--a randomized comparative trial between granisetron alone and granisetron plus methylpred
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anorexia; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Nausea; Vomiting, Anticipatory

1999
[Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Cisplatin; Drug Evaluation; Female; Granisetron; Humans; Infant; Leukemia; Male; Nausea; Neoplasms; Vomiting, Anticipatory

1999
A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1999, Volume: 5, Issue:6

    Topics: Adolescent; Adult; Aged; Antiemetics; Bone Marrow Transplantation; Child; Child, Preschool; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting

1999
[Optimal timing of granisetron administration for the prevention of carboplatin-induced acute emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:14

    Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ovarian Neoplasms; Pilot Projects; Prospective Studies; Time Factors; Uterine Neoplasms; Vomiting, Anticipatory

1999
Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery.
    American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:1 Pt 1

    Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Gynecologic Surgical Procedures; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting

2000
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Pilot Projects; Prochlorperazine; Treatment Outcome; Vomiting

2000
Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin.
    Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:1

    Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Cost-Benefit Analysis; Female; Granisetron; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting, Anticipatory

2000
[Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].
    Bulletin du cancer, 2000, Volume: 87, Issue:3

    Topics: Administration, Oral; Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Double-Blind Method; Female; Granisetron; Humans; Infant; Male; Nausea; Vomiting

2000
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Middle Aged; Nausea; Prednisolone; Treatment Outcome; Vomiting

2000
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:4

    Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting

2000
Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy.
    The oncologist, 2000, Volume: 5, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Sex Factors; Vomiting, Anticipatory

2000
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    British journal of cancer, 2000, Volume: 83, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granisetron; Humans; Life Tables; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ondansetron; Prognosis; Risk; Skin Neoplasms; Survival Analysis; Tamoxifen; Treatment Outcome; Vomiting

2000
Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:2

    Topics: Adult; Aged; Antiemetics; Bone Marrow Transplantation; Double-Blind Method; Drug Evaluation; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Whole-Body Irradiation

2000
Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Cross-Over Studies; Drug Costs; Female; Granisetron; Health Care Costs; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting

2000
[Clinical evaluation of granisetron hydrochloride for nausea and vomiting induced by oral anticancer drugs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Colorectal Neoplasms; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Stomach Neoplasms; Tablets; Vomiting, Anticipatory

2000
Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 2000, Volume: 63, Issue:10

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

2000
Randomized, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy.
    Pharmacotherapy, 2000, Volume: 20, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Emetics; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron

2000
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Neoplasma, 2000, Volume: 47, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting

2000
Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.
    Transplantation proceedings, 2000, Volume: 32, Issue:8

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Indoles; Leukemia; Male; Multiple Myeloma; Myelodysplastic Syndromes; Nausea; Ondansetron; Transplantation, Autologous; Transplantation, Homologous; Tropisetron; Vomiting

2000
Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans.
    American journal of physiology. Gastrointestinal and liver physiology, 2001, Volume: 280, Issue:2

    Topics: Adult; Carbohydrates; Catheterization; Double-Blind Method; Duodenum; Female; Granisetron; Humans; Intubation, Gastrointestinal; Lipids; Male; Middle Aged; Nausea; Nutritional Physiological Phenomena; Pain; Pressure; Proteins; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Stomach

2001
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory

2001
Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Pediatric hematology and oncology, 2001, Volume: 18, Issue:6

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Humans; Indoles; Infant; Male; Nausea; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Tropisetron; Vomiting

2001
Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2001, Volume: 7, Issue:11

    Topics: Administration, Oral; Antiemetics; Costs and Cost Analysis; Double-Blind Method; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Therapeutic Equivalency; Transplantation Conditioning; Vomiting

2001
The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy.
    Cancer investigation, 2001, Volume: 19, Issue:8

    Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antiemetics; Dose Fractionation, Radiation; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Radiotherapy; Tablets; Vomiting

2001
[Nasea injection in the prophylaxis of gastrointestinal reaction induced by chemotherapeutic agents].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Benzimidazoles; Cisplatin; Digestive System; Female; Granisetron; Humans; Male; Middle Aged; Mitomycin; Nausea; Vomiting

2000
[The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2001, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Tropisetron; Vomiting

2001
The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting

2001
A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:6-7

    Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Pyrrolidines; Single-Blind Method; Vomiting

1992
A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Single-Blind Method; Vomiting

1992
Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Pyrrolidines; Single-Blind Method; Vomiting

1992
Oral granisetron--simple and effective: a preliminary report. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Vomiting

1992
Intravenous granisetron--establishing the optimal dose. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Vomiting

1992
A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.
    The Netherlands journal of medicine, 1992, Volume: 40, Issue:5-6

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Netherlands; Serotonin Antagonists; Vomiting

1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 29A, Issue:1

    Topics: Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Vomiting

1992
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis.
    Journal of the National Cancer Institute, 1991, Aug-21, Volume: 83, Issue:16

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Prochlorperazine; Serotonin Antagonists; Vomiting

1991
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting

1991
High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting.
    Investigational new drugs, 1990, Volume: 8, Issue:4

    Topics: Antineoplastic Agents; Double-Blind Method; Drugs, Investigational; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Random Allocation; Serotonin Antagonists; Vomiting

1990
A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1

    Topics: Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Time Factors; Vomiting

1990
A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1

    Topics: Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Headache; Humans; Indazoles; Male; Middle Aged; Nausea; Serotonin Antagonists; Time Factors; Vomiting

1990
The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Sex Factors; Time Factors; Vomiting

1990

Other Studies

108 other study(ies) available for granisetron and Nausea

ArticleYear
Comparison of the Antiemetic Effect of Aprepitant/granisetron and Palonosetron Combined with Dexamethasone in Gynecological Cancer Patients Treated with Paclitaxel and Carboplatin Combination Regimen.
    Die Pharmazie, 2022, 05-01, Volume: 77, Issue:5

    Topics: Anorexia; Antiemetics; Aprepitant; Carboplatin; Dexamethasone; Female; Granisetron; Humans; Nausea; Neoplasms; Paclitaxel; Palonosetron; Retrospective Studies; Vomiting

2022
Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Morpholines; Nausea; Vomiting

2019
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting.
    Journal of clinical pharmacology, 2020, Volume: 60, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Child; Child, Preschool; Clinical Trials as Topic; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Granisetron; Humans; Infant; Male; Middle Aged; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Palonosetron; Treatment Outcome; United States; United States Food and Drug Administration; Vomiting; Young Adult

2020
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
    Journal of cancer research and clinical oncology, 2020, Volume: 146, Issue:4

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Morpholines; Nausea; Transplantation Conditioning; Vomiting

2020
Adherence to ASCO for Prophylaxis of Acute Chemotherapy- Induced Nausea and Vomiting in Iran.
    Asian Pacific journal of cancer prevention : APJCP, 2020, Jun-01, Volume: 21, Issue:6

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Granisetron; Guideline Adherence; Humans; Induction Chemotherapy; Male; Middle Aged; Nausea; Neoplasms; Prognosis; Vomiting

2020
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:8

    Topics: Academic Medical Centers; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting; Young Adult

2020
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2020, Volume: 59, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Multiple Myeloma; Nausea; Prospective Studies; Vomiting; Young Adult

2020
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4

    Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting

2021
Effects of 5-HT
    Clinical and translational science, 2021, Volume: 14, Issue:5

    Topics: Acute Kidney Injury; Aged; Animals; Benzimidazoles; Cisplatin; Disease Models, Animal; Female; Granisetron; Humans; Kidney; Male; Mice; Middle Aged; Nausea; Ondansetron; Organic Cation Transport Proteins; Palonosetron; Renal Elimination; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2021
Granisetron transdermal delivery system is effective in the control of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC) in China.
    Chinese clinical oncology, 2017, Volume: 6, Issue:2

    Topics: Antiemetics; China; Granisetron; Humans; Nausea; Vomiting

2017
Nausea and vomiting: Therapeutic orphans of pediatric oncology.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:10

    Topics: Antiemetics; Child; Child, Preschool; Granisetron; Humans; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2017
Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.
    Oncology, 2017, Volume: 93, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Aprepitant; Cost-Benefit Analysis; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Multiple Myeloma; Nausea; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Vomiting

2017
Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:9

    Topics: Adult; Aged; Aging; Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Prednisone; Quinuclidines; Risk Factors; Rituximab; Sex Characteristics; Treatment Outcome; Vincristine; Vomiting; Young Adult

2017
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Dexamethasone; Female; Genetic Predisposition to Disease; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Vomiting

2018
Hydration requirements with emetogenic chemotherapy: granisetron extended-release subcutaneous versus palonosetron.
    Future oncology (London, England), 2018, Volume: 14, Issue:14

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Female; Fluid Therapy; Granisetron; Humans; Injections, Subcutaneous; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Retrospective Studies; Serotonin Antagonists; Treatment Outcome; Vomiting

2018
Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy.
    Die Pharmazie, 2018, 05-01, Volume: 73, Issue:5

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Bendamustine Hydrochloride; Dexamethasone; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Retrospective Studies; Vomiting

2018
Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019, Volume: 27, Issue:3

    Topics: Adjuvants, Pharmaceutic; Adolescent; Adrenal Cortex Hormones; Anthracyclines; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Induction Chemotherapy; Infant; Lorazepam; Male; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Retrospective Studies; Risk Factors; Vomiting

2019
Hydration requirements in patients receiving highly emetogenic chemotherapy.
    Future oncology (London, England), 2019, Volume: 15, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Female; Fluid Therapy; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Palonosetron; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting; Young Adult

2019
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma].
    Recenti progressi in medicina, 2018, Volume: 109, Issue:11

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Transdermal Patch; Vomiting

2018
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.
    Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:6

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Palonosetron; Prospective Studies; Vomiting

2019
[Out-patient management of nausea and vomiting in multiday therapy of acute myeloid leukemia in the elderly. Use of granisetron in slow-release transdermal formulation. Clinical case].
    Recenti progressi in medicina, 2019, Volume: 110, Issue:3

    Topics: Ambulatory Care; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Middle Aged; Nausea; Quality of Life; Vomiting

2019
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:2

    Topics: Antiemetics; Aprepitant; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Palonosetron; Pyridines; Vomiting

2020
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Female; Granisetron; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Retrospective Studies; Treatment Outcome; Vomiting; Young Adult

2013
Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation.
    Pharmacotherapy, 2013, Volume: 33, Issue:9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Morpholines; Nausea; Retrospective Studies; Transplantation, Homologous; Vomiting

2013
[Comparison of antiemesis effects of granisetron, aprepitant and dexamethasone to palonosetron, aprepitant and dexamethasone in treatment of high-emetic risk chemotherapy-induced nausea and vomiting - a retrospective study for efficacy and safety in a sin
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:5

    Topics: Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Palonosetron; Quinuclidines; Retrospective Studies; Risk; Vomiting

2013
Evaluation of the relation between patient characteristics and the state of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving paclitaxel and carboplatin.
    Archives of gynecology and obstetrics, 2014, Volume: 289, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Dexamethasone; Female; Genital Neoplasms, Female; Granisetron; Humans; Hyperemesis Gravidarum; Hypertension; Middle Aged; Multivariate Analysis; Nausea; Paclitaxel; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Vomiting

2014
[Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
    No shinkei geka. Neurological surgery, 2014, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Child; Child, Preschool; Female; Granisetron; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Nervous System Neoplasms; Radiotherapy; Vomiting; Young Adult

2014
Cost-effectiveness analysis of granisetron-based versus standard antiemetic regimens in low-emetogenic chemotherapy: a hospital-based perspective from Malaysia.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12

    Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Dexamethasone; Drug Therapy, Combination; Follow-Up Studies; Granisetron; Humans; Malaysia; Metoclopramide; Nausea; Neoplasms; Prognosis; Retrospective Studies; Vomiting

2013
Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.
    European journal of drug metabolism and pharmacokinetics, 2015, Volume: 40, Issue:1

    Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Constipation; Creatinine; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Isoquinolines; Models, Biological; Nausea; Oxazines; Palonosetron; Quinuclidines; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2015
Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.
    British journal of pharmacology, 2014, Volume: 171, Issue:11

    Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Eating; Granisetron; Kaolin; Male; Medulla Oblongata; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Pica; Protein Precursors; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; RNA, Messenger; Serotonin Antagonists; Solitary Nucleus; Substance P; Tachykinins

2014
Efficacy of aprepitant for nausea in patients with head and neck cancer receiving daily cisplatin therapy.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22

    Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Prospective Studies; Treatment Outcome; Vomiting

2014
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
    Annals of palliative medicine, 2015, Volume: 4, Issue:1

    Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron

2015
Preclinical evaluation of dual action intranasal formulation intended for postoperative/cancer associated therapies.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Aug-30, Volume: 76

    Topics: Adhesiveness; Administration, Inhalation; Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Antineoplastic Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Excipients; Gels; Granisetron; Hydrogen-Ion Concentration; Ketorolac Tromethamine; Kinetics; Mucociliary Clearance; Nausea; Nociception; Pain, Postoperative; Polymers; Postoperative Nausea and Vomiting; Solubility; Spectrophotometry, Infrared; Technology, Pharmaceutical; Temperature; Viscosity; Vomiting

2015
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.
    International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dexamethasone; Drug Therapy, Combination; Female; Gemcitabine; Granisetron; Humans; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting

2015
Induction and antagonism of pica induced by teriparatide in rats.
    European journal of pharmacology, 2015, Oct-05, Volume: 764

    Topics: Age Factors; Animals; Anorexia; Antiemetics; Diphenhydramine; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Female; Granisetron; Histamine H1 Antagonists; Kaolin; Male; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Ovariectomy; Pica; Prochlorperazine; Rats, Wistar; Serotonin 5-HT3 Receptor Antagonists; Teriparatide

2015
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
    International journal of clinical oncology, 2016, Volume: 21, Issue:3

    Topics: Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Combinations; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Oxonic Acid; Palonosetron; Prospective Studies; Quality of Life; Quinuclidines; Stomach Neoplasms; Surveys and Questionnaires; Tegafur; Vomiting

2016
Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics.
    Pharmaceutical research, 2016, Volume: 33, Issue:5

    Topics: Animals; Antiemetics; Benzamides; Bone Density Conservation Agents; Caco-2 Cells; Gastrointestinal Absorption; Gastrointestinal Motility; Gastrointestinal Tract; Granisetron; Humans; Male; Morpholines; Nausea; Osteoporosis; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Teriparatide; Vomiting

2016
Evaluation of Antiemetic Therapy for Hepatic Transcatheter Arterial Infusion Chemotherapy with Cisplatin.
    Biological & pharmaceutical bulletin, 2016, Volume: 39, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bridged Bicyclo Compounds, Heterocyclic; Catheterization, Peripheral; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Liver; Liver Neoplasms; Male; Middle Aged; Morpholines; Nausea; Oxazines; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2016
Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of 'overall' nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2017, Volume: 23, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Agents; Asian People; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Vomiting

2017
Transdermal patch tailors antinausea treatment.
    Managed care (Langhorne, Pa.), 2008, Volume: 17, Issue:12

    Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Granisetron; Humans; Managed Care Programs; Medical Oncology; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Premedication; Serotonin 5-HT2 Receptor Antagonists

2008
Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting.
    Clinical journal of oncology nursing, 2009, Volume: 13, Issue:6

    Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Neoplasms; Serotonin Antagonists; Vomiting

2009
Transdermal medication delivery helps prevent CINV.
    ONS connect, 2010, Volume: 25, Issue:1

    Topics: Administration, Cutaneous; Antiemetics; Granisetron; Humans; Nausea; Patient Education as Topic; Serotonin Antagonists; Vomiting

2010
Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:8

    Topics: Anaphylaxis; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Female; Granisetron; Humans; Infant; Nausea; Neuroblastoma; Ondansetron; Vomiting

2010
Genetic polymorphisms in the three malaysian races effect granisetron clinical antiemetic actions in breast cancer patients receiving chemotherapy.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cytochrome P-450 CYP3A; Female; Follow-Up Studies; Granisetron; Humans; Longitudinal Studies; Malaysia; Middle Aged; Nausea; Neoplasm Staging; Polymorphism, Genetic; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2011
[Comparison of 1 mg/body and 3 mg/body of intravenous granisetron for the prevention of chemotherapy-induced nausea and vomiting and adverse events in hematological malignancy patients].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Dose-Response Relationship, Drug; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Retrospective Studies; Serotonin Antagonists; Vomiting

2012
Transdermal granisetron: a guide to its use in preventing nausea and vomiting induced by chemotherapy.
    CNS drugs, 2012, Sep-01, Volume: 26, Issue:9

    Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Granisetron; Humans; Multicenter Studies as Topic; Nausea; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Vomiting

2012
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult

2012
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
    Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Resistance; Droperidol; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Mastectomy; Methotrexate; Metoclopramide; Middle Aged; Models, Biological; Narcotics; Nausea; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Vomiting

2013
Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
    Journal of gastroenterology, 2013, Volume: 48, Issue:11

    Topics: Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Combinations; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasm Staging; Oxonic Acid; Prospective Studies; Psychometrics; Quality of Life; Stomach Neoplasms; Tegafur; Treatment Outcome; Vomiting

2013
Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Feb-15, Volume: 70, Issue:4

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Hematologic Neoplasms; Hospitals, University; Humans; Male; Middle Aged; Morpholines; Nausea; Retrospective Studies; Treatment Outcome; Vomiting; Young Adult

2013
Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
    Arzneimittel-Forschung, 2002, Volume: 52, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Benzimidazoles; Dose-Response Relationship, Drug; Emetics; Granisetron; Humans; Injections, Intravenous; Ipecac; Male; Nausea; Piperidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Time Factors; Vomiting

2002
Patient outcomes after therapeutic interchange of dolasetron for granisetron.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, May-15, Volume: 60, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cohort Studies; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Quinolizines; Therapeutic Equivalency; Treatment Outcome; United States; Vomiting

2003
Low-dose granisetron for prophylaxis of acute chemotherapy-induced nausea and vomiting: a pilot study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brazil; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Pilot Projects; Serotonin Antagonists; Surveys and Questionnaires; Vomiting

2005
5HT3-receptor antagonists as antiemetics in cancer.
    Drug and therapeutics bulletin, 2005, Volume: 43, Issue:8

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vomiting

2005
Biochronomer technology.
    Expert opinion on drug delivery, 2005, Volume: 2, Issue:1

    Topics: Anesthetics, Local; Chemistry, Pharmaceutical; Clinical Trials as Topic; Delayed-Action Preparations; Drug Delivery Systems; Gels; Granisetron; Humans; Hydrolysis; Mepivacaine; Nausea; Pain, Postoperative; Polyanhydrides; Polyesters; Polymers; Serotonin Antagonists; Solubility; Surface Properties; Time Factors; Vaccines, DNA

2005
Re: The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
    American journal of clinical oncology, 2005, Volume: 28, Issue:6

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Electrocardiography; Granisetron; Heart Rate; Humans; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2005
[Relationship between neurotransmitter blood noradrenalin and nausea/emesis after chemotherapy for lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:7

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Catecholamines; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Lung Neoplasms; Methylprednisolone; Metoclopramide; Nausea; Neurotransmitter Agents; Norepinephrine; Serotonin; Taxoids; Vomiting, Anticipatory

2006
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2006, Volume: 12, Issue:2

    Topics: Antiemetics; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Ondansetron; Organoplatinum Compounds; Palonosetron; Quinolizines; Quinuclidines; Treatment Outcome; Vomiting

2006
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2007
Antiemetic agents.
    Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:8 Suppl

    Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting

2007
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2007, Volume: 13, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2007
Intractable nausea and vomiting successfully related with granisetron 5-hydroxytryptamine type 3 receptor antagonists in Palliative Medicine.
    Palliative medicine, 2007, Volume: 21, Issue:8

    Topics: Antiemetics; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Palliative Care; Treatment Outcome; Vomiting

2007
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Eating; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting

2008
[Effective measures against side effects by increasing ACNU dose for malignant glioma: effects on digestive organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12

    Topics: Adult; Aged; Anorexia; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Granisetron; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nausea; Nimustine; Vomiting

1994
Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 10

    Topics: Administration, Oral; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Serotonin Antagonists; Vomiting

1995
[Efficacy of the granisetron/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey].
    Annales pharmaceutiques francaises, 1995, Volume: 53, Issue:4

    Topics: Antiemetics; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Drug Therapy, Combination; Female; Granisetron; Health Surveys; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Prospective Studies; Serotonin Receptor Agonists; Vomiting

1995
The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:2

    Topics: Animals; Cisplatin; Disease Models, Animal; Female; Granisetron; Male; Nausea; Ondansetron; Swine; Time Factors; Vomiting

1995
[The efficacy of granisetron as a prophylactic anti-emetic agent used in conjunction with MCNU and VP16 chemotherapeutic regimens in the management of a pediatric case of hypothalamic anaplastic astrocytoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Etoposide; Glioblastoma; Granisetron; Humans; Hypothalamic Neoplasms; Interferon-beta; Male; Nausea; Nitrosourea Compounds; Vomiting

1995
Antiemetic properties of granisetron.
    The New England journal of medicine, 1995, Jun-15, Volume: 332, Issue:24

    Topics: Costs and Cost Analysis; Granisetron; Humans; Nausea; Vomiting

1995
[Value of granisetron in the prevention of digestive disorders in total body irradiation].
    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique, 1994, Volume: 81, Issue:1

    Topics: Adult; Aged; Bone Marrow Transplantation; Combined Modality Therapy; Female; Granisetron; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Nausea; Radiotherapy Dosage; Treatment Outcome; Vomiting; Whole-Body Irradiation

1994
Granisetron enters antiemetic market.
    American journal of hospital pharmacy, 1994, Jun-01, Volume: 51, Issue:11

    Topics: Antineoplastic Agents; Granisetron; Humans; Nausea; Product Surveillance, Postmarketing; Vomiting

1994
Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret.
    Pharmacology, 1994, Volume: 48, Issue:5

    Topics: Animals; Cisplatin; Dose-Response Relationship, Drug; Female; Ferrets; Granisetron; Male; Nausea; Premedication; Vomiting; Whole-Body Irradiation

1994
The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.
    British journal of cancer, 1994, Volume: 69, Issue:5

    Topics: Female; Granisetron; Humans; Longitudinal Studies; Male; Nausea; Retrospective Studies; Vomiting, Anticipatory

1994
Repeated use of granisetron in patients receiving cytostatic agents.
    Cancer, 1993, Jun-15, Volume: 71, Issue:12

    Topics: Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Constipation; Female; Granisetron; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Remission Induction; Serotonin Antagonists; Vomiting

1993
[The prevention of CDDP-induced emesis with granisetron].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:8

    Topics: Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting

1993
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12

    Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting

1993
Granisetron (Kytril): a survey of use in clinical practice in Switzerland.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1995, Volume: 3, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Drug Utilization; Drug Utilization Review; Female; Granisetron; Humans; Male; Medical Oncology; Middle Aged; Nausea; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Surveys and Questionnaires; Switzerland; Vomiting

1995
Re: 'Cost-effectiveness of 5-hydroxytryptamin3 receptor antagonists: a retrospective comparison of ondansetron and granisetron'.
    Anti-cancer drugs, 1996, Volume: 7, Issue:1

    Topics: Cost-Benefit Analysis; Granisetron; Nausea; Ondansetron; Salvage Therapy; Serotonin Antagonists; Vomiting

1996
Expanded use of oral granisetron.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Aug-01, Volume: 53, Issue:15

    Topics: Administration, Oral; Antiemetics; Bone Marrow Transplantation; Granisetron; Humans; Injections, Intravenous; Nausea; Vomiting

1996
Tardive dyskinesia as a result of long-term prochlorperazine use.
    Southern medical journal, 1996, Volume: 89, Issue:10

    Topics: Antiemetics; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Prochlorperazine; Time Factors; Vomiting

1996
Always more "setrons": how many do we need?
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indoles; Nausea; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting

1997
[Antiemetic efficacy of granisetron in repeated CAF chemotherapy after breast cancer operation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Humans; Middle Aged; Nausea; Postoperative Period; Vomiting

1997
Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy.
    The Kaohsiung journal of medical sciences, 1997, Volume: 13, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Vomiting

1997
Fighting nausea in the '90s: more and better anti-emetics can help.
    Journal of the National Cancer Institute, 1997, Sep-03, Volume: 89, Issue:17

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Granisetron; Humans; Isonipecotic Acids; Nausea; Ondansetron; Serotonin Antagonists; Substance P; Vomiting

1997
Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Utilization; Female; Granisetron; Guideline Adherence; Humans; Male; Nausea; Ondansetron; Practice Guidelines as Topic; Quality Assurance, Health Care; Serotonin Antagonists; Vomiting

1998
Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
    Radiation research, 1998, Volume: 149, Issue:6

    Topics: Animals; Antiemetics; Gamma Rays; Granisetron; Macaca fascicularis; Male; Nausea; Neutrons; Ondansetron; Radiation Injuries, Experimental; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting

1998
[Therapeutic potential of Granisetron (Kitryl) for the prevention of nausea and vomiting induced by cytostatic drugs].
    Voprosy onkologii, 1998, Volume: 44, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting

1998
Inappropriate use of placebo.
    British journal of anaesthesia, 1998, Volume: 80, Issue:3

    Topics: Antiemetics; Ear, Middle; Granisetron; Humans; Nausea; Placebos; Postoperative Complications; Vomiting

1998
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:3

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Haloperidol; Hematopoietic Stem Cell Transplantation; Humans; Lorazepam; Middle Aged; Nausea; Palliative Care; Treatment Outcome; Vomiting

1998
Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Jun-15, Volume: 55, Issue:12

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vomiting

1998
Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles.
    British journal of cancer, 1998, Volume: 77, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Vomiting

1998
Stability of granisetron hydrochloride in two oral suspensions.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-01, Volume: 55, Issue:23

    Topics: Administration, Oral; Antiemetics; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Granisetron; Humans; Nausea

1998
Economics of serotonin 5-HT3 antagonists.
    PharmacoEconomics, 1996, Volume: 10, Issue:4

    Topics: Drug-Related Side Effects and Adverse Reactions; Granisetron; Humans; Nausea; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting

1996
Neurokinin antagonism and chemotherapy-induced emesis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Acetals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Morpholines; Multicenter Studies as Topic; Nausea; Neurokinin-1 Receptor Antagonists; Randomized Controlled Trials as Topic; Substance P; Vomiting

1999
Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:5

    Topics: Adult; Aged; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluorouracil; Granisetron; Head and Neck Neoplasms; Humans; Male; Manifest Anxiety Scale; Middle Aged; Nausea; Vomiting

2001
Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:8

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cost Control; Drug Costs; Evidence-Based Medicine; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Practice Guidelines as Topic; Prospective Studies; Quality of Health Care; Vomiting

2001
Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
    Gynecologic oncology, 2002, Volume: 85, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Serotonin Antagonists; Taxoids; Vomiting

2002
[Nausea and vomiting in chemotherapy].
    Revue de l'infirmiere, 1992, Volume: 42, Issue:4

    Topics: Antineoplastic Agents; Clinical Protocols; Granisetron; Humans; Indazoles; Nausea; Vomiting

1992
Dose granisetron remain effective over multiple cycles? The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Serotonin Antagonists; Sex Factors; Vomiting

1992
The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 29A, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indazoles; Models, Theoretical; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1992
Caring for the cancer patient: managing emesis now. An interactive workshop. Proceedings of a satellite symposium to the 6th European Conference on Clinical Oncology. Florence, October 1991.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Vomiting

1992
Who should receive a 5-HT3 antagonist?
    Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827

    Topics: Acute Disease; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting

1992
Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:9

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Granisetron; Humans; Indazoles; Male; Nausea; Prognosis; Serotonin Antagonists; Time Factors; Vomiting

1991
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Cisplatin; Doxorubicin; Drug Evaluation; Drug Tolerance; Granisetron; Humans; Indazoles; Nausea; Pyrazoles; Serotonin Antagonists; Vomiting

1990
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:1

    Topics: Adult; Aged; Antiemetics; Basal Metabolism; Chromatography, High Pressure Liquid; Cisplatin; Female; Granisetron; Half-Life; Humans; Indazoles; Male; Middle Aged; Nausea; Pyrazoles; Serotonin Antagonists

1989
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Tolerance; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Pyrazoles; Serotonin Antagonists; Vomiting

1989
The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.
    BMJ (Clinical research ed.), 1988, Jul-09, Volume: 297, Issue:6641

    Topics: Cisplatin; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Indazoles; Male; Nausea; Pyrazoles; Serotonin Antagonists

1988
BRL 43694: a novel antiemetic to prevent nausea and vomiting induced by chemotherapy.
    Journal of the National Cancer Institute, 1988, Oct-19, Volume: 80, Issue:16

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Pyrazoles; Vomiting

1988